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ON THE COVER
This year, the George 
Washington University School 
of Medicine and Health 
Sciences (SMHS) hosted 
its first-ever Art of Science 
Contest. Looking at the 
image gracing the cover of 
Fusion, one might not know 
the bright purple and green 
colors represent olfactory bulb 
interneurons and astrocytes in 
the brain, but that’s the beauty 
of art: there’s more to it than 
meets the eye. 
The image came from grand prize winner first-year MD student 
Aslam Akhtar, PhD, who said a push from classmates and class 
discussions about the olfactory bulb neurons — the neurons 
responsible for our sense of smell — led him to enter his image 
in the contest.
The four contest winners — chosen by a team of SMHS deans, 
students, and staff — will have their images displayed in the 
SMHS Dean’s Suite in Ross Hall.
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With the goa l of highlighting 
the  novel research carried out 
by the medical students of the 
George Washington University 
(GW ) School of Medicine and 
Health Sciences (SMHS), we proudly 
present the 2018 edition of Fusion. 
This journal is a medical student-run 
publication; everything from the 
abstracts to the cover artwork was 
provided by our peers. This year’s 
collection of abstracts reflects the 
diverse nature of research being 
done at SMHS, from research in 
basic science and clinical medicine 
to medical education and public 
health. 
Our goal as this year’s co-presi-
dents of the William H. Beaumont 
Medical Research Honor Society 
was to build upon the tremendous 
success of last year’s journal. We 
believe that our growing journal 
reflects an increasing trend of SMHS 
students’ participation in research 
and an expanding institutional 
emphasis on research at GW. We 
also hope that this journal inspires 
incoming and matriculated medical 
students to engage in research at 
GW and become a part of the flour-
ishing SMHS research community.
We would like to offer spe-
cia l congratulations to Nicole 
Casasanta, Dara Baker, and Christina Pugliese, 
this year’s first-, second-, and third-prize win-
ners, respectively, of the William H. Beaumont 
Medical Honor Society Student Research 
Award. Their research stood out among a 
truly impressive body of work and merits the 
opportunity to present the research to fac-
ulty and students at the 23rd Annual SMHS 
Research Day.
This year’s edition of Fusion would not 
have been possible without the support of 
numerous individuals. First, we express our 
heartfelt gratitude to Fusion’s faculty adviser, 
Alison K. Hall, associate dean for research 
workforce development. We would also like 
to thank Laura Radville Wittenbach, research 
program associate, for her invaluable logistical 
support. In addition, we thank the SMHS 
Office of Communications and Marketing for 
the design and production of Fusion. And last, 
but not least, we offer a special thank you to 
our fellow classmates — those who volunteered 
their time to our Editorial Board, as well as 
our authors, without whom this journal would 
not exist.
We hope you enjoy the 2018 edition of 
Fusion, a collection of abstracts we believe 
reflects the unique and impressive research 
done by GW medical students in a variety of 
disciplines. To next year’s authors and editors: 
we hope you are inspired by the breadth of 
research done at GW SMHS, and we encourage 
you to submit your abstracts and get involved 
with the 2019 edition of Fusion and the William 
H. Beaumont Medical Honor Society!
Janine Amirault, MSII
Sarah McCormack, MSII 
Co-Presidents of the  





 Letters:  
LETTERS 3
I’m delighted to assist the student editors with 
this edition of Fusion. This is an exciting time 
to be at the George Washington University 
School of Medicine and Health Sciences, with 
new initiatives in our research programs that 
bring greater opportunities for medical stu-
dent research. You will find examples of the 
broad range of research pursued by students, 
from basic biomedical discovery to clinical 
and translational research with patients to 
initial translation to practice and communi-
ties, on every page of this edition of Fusion. 
This year, the editors asked authors 
about their roles in the projects, and medical 
students described numerous sophisticated 
approaches and activities including chart 
review, data collection, molecular biology 
techniques, f ield studies, study design, 
assisting in IRB applications, and statistical 
analyses, to name a few. I am particularly 
impressed that so many students reported 
findings derived from just 
one summer of research! It 
was a real challenge to select 
the abstract winners from a 
collection of such excellent 
projects, and I applaud the 
hard work shown by all the 
students and their mentors.
Fusion is just one effort 
of the William Beaumont 
Research Honor Society to 
engage GW medical stu-
dents in the excitement and 
impact of research, and I wel-
come you to explore pp. 4-49 
for additional ways to join 
this community of scholars. 
Alison K. Hall, PhD,  Associate Dean for 
Research Workforce Development, Professor 
of Neurology
From the Faculty Adviser
 Letters:  
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EXTERNAL FELLOWSHIPS
Research track member Sharjeel Chaudhry, 
MSIII, won the Sarnoff Cardiovascular 
Research Fellowship in 2017 to 
conduct research at Harvard 
Medical School. Fellowship 
opportunities are listed 
at https://tinyurl.com/
y9vj54gj.
GW Medical Student Research
RESEARCH SCHOLARLY 
CONCENTRATION
About 50 students per year elect to 
join the Clinical and Translational 
Research Scholarly Concentration. 
In this program, students 
conduct mentored research over 
the summer between MSI and 
MSII, attend research lectures, 
and follow-up with research 
scholarship.  




The GW School of Medicine and Health Sciences offers 
a variety of competitive scholarship programs to assist in 
funding exceptional projects in health care and medicine. In 
2017, 33 students won a Gill Summer Research Fellowship 





grant from the 
American College 
of Rheumatology 
that funded summer 
research and travel to 
its 2017 annual meeting.
METEOR PROGRAM
The Mentored Experience to Expand Opportunities 
in Research is a competitive fellowship for 
underrepresented-in-medicine students. 
Incoming medical students attend two 
funded summer internships (before 
matriculation and in the summer 
between MSI and MSII) and enroll 




To learn more, please contact 
the Office of Student Professional 
Enrichment at www.smhs.gwu.edu/ospe.
Stephanie Kao, MSII, won a 2017 Gill Fellowship to conduct cancer research.
5
TRAVEL AWARDS: Medical students are 
encouraged to apply for outside funding for summer 
or year-out research, or for travel to meetings. The 
Scholarly Concentration website has a list of funding 
opportunities for summer research, travel, and yearlong 
fellowships (https://tinyurl.com/y9vj54gj).
YEAR-OUT
Medical students may elect to take 
a year off from studies at GW to 
conduct research full-time at GW, 
NIH, or other institutions. This is a 
great way to fully immerse yourself 
in a research project and form 
connections at other institutions. 













Prize will be 
presented 







WILLIAM H. BEAUMONT RESEARCH HONOR SOCIETY
Named after William 
Beaumont, a pio-
neer in physiologic 
investigation, the 
William H. Beaumont 
Medical Research 
Honor Society was 
established to edu-
cate and inform 
medical students 
about research. Any 
GW medical stu-
dent interested in 
research is welcome 
to join. The 2017–18 
Co-Presidents are 
Sarah McCormack 
and Janine Amirault. 
See https://tinyurl.
com/y7yuwr6w.
Sarah McCormack, MSII, co-president of the 
William H. Beaumont Medical Research Honor 
Society, won first place for medical student 
posters at the 2017 Research Days.
Medical students have numerous opportunities to engage in research and scholarship
GW Research Days is an annual event in the spring that 
celebrates research across GW. Students and post-doctoral 
fellows present posters, giveoral presentations and 
compete for cash prizes. For more information, visit  
researchdays.gwu.edu/.
At Research Days 2017, Sharjeel Chaudhry, Lauren Jacobs, and Brendan 
Campbell accepted the William Beaumont Research Award from former Fusion 
editors Michael Froehlich and Jacob Rubin.
Justin Buro took a year out in 2017 to conduct 
research at the Laboratory of Bioregenerative 
Medicine and Surgery at Weill Cornell Medical 
College.
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Oncotype DX is a commercially avail-
able test which generates a recurrence 
score (RS) based on the molecular fea-
tures of an individual’s breast cancer. 
The RS is used to stratify hormone 
receptor positive breast tumors into 
those likely to respond to cytotoxic 
chemotherapy. Women and men with 
hereditary cancers tend to have tumors 
that are chemosensitive.1 However, 
studies show that women with known 
hereditary breast cancer can have a 
more aggressive clinical course and 
poor clinical outcomes when com-
pared to sporadic breast tumors. We 
hypothesize that a high RS may harbor 
a signal of potential hereditary risk. 
This analysis aims to identify whether 
breast cancer patients with hereditary 
cancer syndromes have a dispropor-
tionate amount of high RS compared 
to sporadic cases.
Individuals with a personal his-
tory of breast cancer who received 
treatment at participating research 
facilities and had hormone receptor 
positive breast cancer, Oncotype DX 
testing and hereditary cancer muta-
tion testing were included. Oncotype 
DX RS was recorded along with the 
type of genetic testing and the genetic 
testing results. RS was categorized as 
low (0-17), intermediate (18-30), and 
high (31+). Those with deleterious 
mutations in any known hereditary 
cancer gene were considered positive. 
Individuals with a variant of uncer-
tain significance (VUS) or negative 
genetic testing result were considered 
negative. Difference in distribution of 
tumors with low, intermediate, and 
high Oncotype DX results in those 
with hereditary breast cancers com-
pared to those with sporadic breast 
cancers was determined with Chi-
square and Chi-square difference of 
proportions. 
Data from 1,799 patients with 
Oncot y pe DX testing from t wo 
clinical sites were collected from 2008. 
Of those, 499 underwent genetic risk 
assessment. Mutations were identified 
in 47 patients and included the fol-
lowing genes: BRCA2 (20); CHEK2 
(6); BRIP1 (4); MSH6 (3); PALB2 
(3); ATM (3); BRCA1 (2); NBN (2); 
MUTYH (2); APC (1); MRE11A (1); 
P53 (1). Of those testing positive for 
a deleterious mutation, the number 
of patients with RS results in each 
category were 17, 17, and 13 for low, 
intermediate, and high, respectively. 
For those considered negative on 
hereditary cancer panel testing, the 
RS results were 267, 149, and 36, 
respectively. Of those with high RS, 
28% had deleterious mutations. Chi 
square test was statistically signifi-
cant for a difference between the RS 
of those with deleterious hereditary 
mutations versus those with sporadic 
cancers (p = 0.000029). Chi square test 
for difference of proportions was also 
statistically significant for a larger pro-
portion of high RS in mutation carriers 
(p=0.0001). With removal of BRCA2 
(20) and BRCA1 (2) carriers from the 
analysis, the Chi square test for differ-
ence of proportions was still statisti-
cally significant for a larger proportion 
of high RS seen in non-BRCA1/2 muta-
tion carriers (p=0.0069). 
Breast cancer patients with heredi-
tary cancer syndromes have a dis-
proportionate amount of high RS 
scores compared to sporadic cases. 
 William H. Beaumont Research Prize Winners: 













1 The George 
Washington 
University, School 
of Medicine and 
Health Sciences, Washington, D.C.
 Continued on p. 7
Relationship Between Hereditary Cancer Syndromes and 























7BEAUMONT RESEARCH PRIZE WINNERS
Non-BRCA1/2 mutation carriers also 
had a significantly higher propor-
tion of high RS scores compared to 
sporadic cancer patients. High RS 
may indicate a higher likelihood of 
harboring a hereditary cancer syn-
drome. This may implicate a high 
Oncotype DX recurrence score as an 
independent risk factor for harboring 
a genetic mutation and thus prompt 
genetic testing regardless of family his-
tory. Further investigation with larger 
numbers and multivariate analysis is 
needed to validate if a high RS serves 




1. Narod SA, Metcalfe K, 
Lynch HT, et al. Should all 
BRCA1 mutation carriers 
with stage I breast cancer 
receive chemotherapy? 
B r e a s t  C a n c e r  R e s 
Treat.2013;138: 273-279.
2. Shah SA, Patil S, Dickler 
MN, et al. Twenty-one-
gene recurrence score 
assay in BRCA-associated 
versus sporadic breast cancers: Differences 
based on germline mutation status. Cancer. 
2016; 122(8), 1178-1184. 
 William H. Beaumont Research Prize Winners: 
Gastric cancer remains the third 
foremost cause of cancer deaths 
worldwide. The leading cause of 
gastric cancer, Helicobacter pylori, 
is thought to drive carcinogenesis 
by inducing chronic inflammation. 
One pathway implicated in the host 
immune response involves poly-
amines, which have been shown by 
our laboratory to contribute to gastric 
carcinogenesis.1, 2  
Difluoromethylornithine 
(DFMO), an inhibitor of ornithine 
decarboxylase (ODC), the rate-lim-
iting enzyme for polyamine synthesis, 
reduces gastric inflammation and pro-
gression to cancer in gerbils infected 
w ith H. pylori.3 Pa radox ica l ly, 
cell-specific deletion of the Odc gene 
in macrophages increased inf lam-
mation in murine experiments, indi-
cating the likely involvement of 
alternative mechanisms by which 
DFMO could be mediating cancer 
progression, including direct effects 
on the bacteria.4, 5 We hypothesize 
that DFMO modulates the interac-
tion between H. pylori and gastric 
cancer by affecting the bacteria 
exposed to oxidative stress generated 
in an inflammatory environment.
Strains for H. pylori, derived from 
the parental strain 7.13, were either 
grown on plates passaged 19 times 
with or without DFMO exposure, 
or harvested from gerbil stomach 
tissue after 12 weeks with or without 
exposure to DFMO in drinking 
water. Murine macrophages of the 
RAW 264.7 cell line and H. pylori 
strains were co-cultured, and mRNA 
was harvested from cells six hours 
post-infection. RT-PCR was used to 
analyze expression of genes encoding 
proteins indicative of M1 macrophage 
activation response (NOS2, TNF-‹, 
 Continued on p. 8
Dara Baker, 
MSII 







 Continued from p. 6
TABLE: Influence of hereditary cancer mutations on 
Oncotype DX recurrence score in breast cancer patients
The Role of DFMO in Helicobacter Pylori Infection: 








LOW (%) 267 (59) 17(36)
INTERMEDIATE (%) 149 (33) 17 (36)
HIGH (%) 36 (8) 13 (28)
FIGURE 1: Real Time PCR for katA (Catalase) chemotaxis receptor TlpB in H.pylori 
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IL-1®). For the second focus, we 
cultured H. pylori 7.13 in liquid media 
over 24 hours with 50 mM DFMO, 
50 mM ornithine, or no additional 
reagent. At each two-hour time point, 
we noted the OD600nm and isolated 
RNA. To assess oxidative response, 
we used RT-PCR to compare mRNA 
expression of genes involved in H. 
pylori defense mechanisms to ROS/
RNS, including sodB and tpx. We 
performed RT-PCR for katA and tlpB 
for the parental, in vitro passaged, 
and gerbil output strains. Last, we 
grew the parental strain and 4 gerbil 
output strains in Brucella broth, or 
broth treated H2O2, and plotted 
growth curves. 
In co-culture experiments, M1 
gene expression levels did not differ 
between macrophages infected with 
DFMO-treated or control strains. In 
our analysis of H. pylori gene expres-
sion, we found sodB and tpx genes to 
be induced at the two and four hour 
time points in the samples collected 
from the DFMO-treated compared to 
ornithine-treated media or untreated 
controls. Furthermore, expression of 
katA and tlpB were lower in DFMO 
output versus control output strains 
(Figure 1). Bacterial growth curves 
demonstrated attenuated growth in 
H2O2-treated DFMO-exposed H. 
pylori strains compared to untreated 
DFMO-exposed controls (Figure 
2). Additionally, unexposed control 
gerbil output strains showed no dif-
ference in growth in acutely H2O2-
treated strains compared to untreated 
controls. 
Our results from this study suggest 
that chronic exposure of H. pylori to 
DFMO impedes bacterial response 
to environmental stress by affecting 
expression of oxidative defense genes. 
These data also imply that treatment 
with DFMO may be contributing to 
environmental oxidative stress, which 
leads to an immediate response by 
the bacteria to prevent ROS-induced 
DNA damage. Further studies may 
establish the specific role of DMFO 
in the modulation of H. pylori growth 
that hinders the clinical progression 
of ulcerative disease through induc-
tion of oxidative stress. The implica-
tions are that DFMO has benefits in 
its effects on H. pylori that add to its 
chemopreventive potential in patients 
afflicted with chronic gastritis.
REFERENCES 
1. Chaturvedi R, Asim M, Hoge S, Lewis ND, Singh 
K, Barry DP, de Sablet T, Piazuelo MB, Sarvaria 
AR, Cheng Y, Closs EI, Casero RA, Jr., Gobert 
AP, Wilson KT. Polyamines impair immu-
nity to Helicobacter pylori by inhibiting 
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DM, Delgado AG, Schneider BG, Israel DA, 
Romero-Gallo J, Nagy TA, Morgan DR, Murray-
Stewart T, Bravo LE, Peek RM, Jr., Fox JG, 
Woster PM, Casero RA, Jr., Correa P, Wilson KT. 
FIGURE 2: Growth curves for H.pylori 7.13 strain and four gerbil output strains 
cultured in liquid media with treatments of 500 mM or 1mM H2O2  at varying time points
Increased Helicobacter pylori-associated 
gastric cancer risk in the Andean region 
of Colombia is mediated by spermine 
oxidase. Oncogene. 2015;34: 3429-40. 
PMCID: PMC4345146.
3. Barry DP, Asim M, Leiman DA, de Sablet T, 
Singh K, Casero RA, Chaturvedi R, Wilson 
KT. Dif luoromethylornithine is a novel 
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CagA translocation, and interleukin-8 
Induction. PLoS One. 2011;6: e17510. 
PMCID: PMC3046249.
4. Hardbower DM, Asim M, Luis PB, Singh K, 
Barry DP, Yang C, Steeves MA, Cleveland JL, 
Schneider C, Piazuelo MB, Gobert AP, Wilson 
KT. Ornithine decarboxylase regulates 
M1 macrophage activation and mucosal 
inflammation via histone modifications. 
Proc Natl Acad Sci USA. 2017;114: E751-
E60. PMCID: PMC5293075.
5. Gobert AP and Wilson KT. NADPH-depen-
dent generation of ROS during Helico-
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guise. Free Radical Biology and Medicine. 
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 Continued from p. 7






































Parental 7.13 Control-1 Control-2
9BEAUMONT RESEARCH PRIZE WINNERS
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Diarrhea remains the second leading 
cause of death among children ages 
1–59 months, with nearly half of 
deaths occurring in Sub-Saharan 
Africa.1 World Health Organization 
(WHO) guidelines on the manage-
ment of childhood diarrhea recom-
mend oral rehydration salts (ORS), 
continued feeding or breastfeeding, 
and zinc supplementation for all chil-
dren with diarrhea to prevent dehy-
dration and malnutrition; antibiotics 
only for bloody diarrhea (i.e. probable 
shigellosis), suspected cholera, or 
severe non-intestinal infections (e.g. 
pneumonia or sepsis); and avoidance 
of antidiarrheal drugs and antiemetics 











1 Department of Microbiology, Immunology 
and Tropical Medicine, The George 
Washington University, School of Medicine 
and Health Sciences 
2 Center of Tropical Medicine and Travel 
Medicine, Department of Infectious 
Diseases, Division of Internal Medicine, 
University of Amsterdam, Amsterdam, 
Netherlands 
3 Institute of Tropical Medicine, University of 
Tübingen, Tübingen, Germany 
4 Centre de Recherches Médicales de 
Lambaréné (CERMEL), Albert Schweitzer 
Hospital, Lambaréné, Gabon
Gabon is an upper-middle income 
country in Sub-Saharan Africa for 
which there is a lack of recent high 
quality data on the etiology and man-
agement of childhood diarrhea.3 This 
prospective study aimed to describe 
the etiolog y, clinical symptoms, 
associated demographic factors, and 
management of hospitalized and out-
patient cases of diarrhea in Gabonese 
children under 5 years of age. 
Children ≤ 59 months presenting 
to the Albert Schweitzer or George 
R a w i r i  Reg ion a l  Hospit a l s  i n 
N = 45
Gender Female 26 (58%)
Male 19 (42%)
Age 0–11 mos 20 (44%)
12–23 mos 17 (38%)
24–59 mos 8 (18%0
Mean time since onset of diarrhea before presentation to 
hospital
4.7 [1, 21] days
Mean number of stools in last 24 hr 4.1 [1,9]
Macroscopic blood in stool 8 (18%)
Mucous in stool 30 (67%)
Fever (body temperature ≥ 38°C) 34 (76%)
Vomiting 17 (38%) 
Extra-intestinal
27 (60%) [25 pulmonary 
signs, including 16 cough, 
5 bronchitis, 4 rhinitis; 1 
anemia; 1 dermatologic sign]













Never breastfeed 1 (12%)
Children ≥6 mos Breastfed ≥ 6 mos 20 (61%)
Breastfed < 6 mos 10 (30%)
Never breastfed 3 (9%)
TABLE: Clinical and demographic characteristics of cases
 Continued on p. 10
Etiology and Management of Hospitalized and Outpatient 
Diarrhea Among Children Less Than 5 Years of Age in 
Lambaréné, Gabon 
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FIGURE: Treatments received by hospitalized and outpatient children
■  Hospitalized ■  Outpatient















Lambaréné, Gabon (February-July 
2017) were included if they had ≥ 3 
liquid stools per day within the past 
three days. Both outpatient and 
hospitalized cases were included. 
Dehydration and nutritional status 
were defined according to WHO stan-
dards.2 Diarrheaogenic Escherichia 
coli, Salmonella enterica, and Shigella 
spp. were detected using conventional 
culture techniques. Samples were 
tested for rotavirus, adenovirus, and 
Cryptosporidium spp. antigens using 
commercial rapid immunoassays. 
Multiplex PCR was used to detect 
Cryptosporidium spp., Giardia intes-
tinalis, and Cyclospora cayetanensis 
on extracted DNA from feces.
Forty five children were included 
in the study, 34 of whom were hos-
pitalized. Clinical and demographic 
characteristics are described in 
Table  1. Prescribed treatments are 
summarized in Figure 1. Forty-nine 
percent of children were infected 
with one or more of the above sought-
for pathogens, most com mon ly 
with Giardia intestinalis (28.9%) or 
Cryptosporidium spp. (24.4%).
This study highlights the man-
agement of childhood diarrhea in 
Lambaréné, Gabon, in the context 
of WHO guidelines. Only 33% and 
36% of hospitalized and outpatient 
children, respectively, received ORS. 
Zinc was given to only one (3%) 
hospitalized patient and was never 
prescribed in the outpatient setting. 
Moreover, despite potentially harmful 
side effects in pediatric patients and 
their lack of benefit, antidiarrheal 
drugs were frequently given to both 
hospitalized (48%) and outpatient 
(73%) children.
Antibiotics were prescribed in 
85% and 36% of hospitalized and 
outpatient cases, respectively, while 
only eight children (18%) presented 
with macroscopic blood in the stool. 
This observed overuse of antibiotics 
is consistent with previous studies and 
is concerning given reports of high 
levels of antimicrobial resistance in 
Sub-Saharan Africa.5 
Previous studies have shown that 
acute malnutrition is a risk factor for 
severe diarrhea and death during hos-
pitalization.4 Seventy nine percent of 
children presented with severe acute 
malnutrition and an additional 10% 
with moderate acute malnutrition. 
To prevent malnutrition, WHO 
recommends exclusive breastfeeding 
for the first six months of life.2 While 
61% of children ≥6 months had been 
breastfed for at least the first six 
months of life, 21% of all children had 
never been breastfed. 
This study emphasizes the need 
for continued education of healthcare 
workers and communities regarding 
WHO recommended treatment of 
childhood diarrhea. This includes 
ORS, zinc supplementation, and 
continued feeding or breastfeeding 
to prevent dehydration and malnu-
trition; avoidance of antidiarrheal 
drugs; and restricted use of antibiotics 
to limit the spread of antimicrobial 
resistance.  
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 Basic Science:  
During the reproductive cycle, altered 
calcium homeostasis is obser ved 
due to variable demand for min-
eral requirements. This results in 
increased bone resorption during the 
time period leading up to parturition 
and subsequent lactation. During lac-
tation, women will lose 1-3% of bone 
mineral density per month, which is 
comparable to the loss experienced 
annually post-menopausal.1 The pur-
pose of this study was to determine 
the effect of parity on bone formation 
in middle-aged mice.
C57BL/6J mice were obtained and 
breeding pairs were established to 
obtain timed pregnancies. Females 
were retired from breeding when litter 
size decreased, which was approxi-
mately at 9 to 12 months of age, and 
then enrolled in the current study. 
Mice were then euthanized and the 
right distal femurs were analyzed by 
standard micro-computed tomog-
raphy. For each femur, the trabecular 
bone compartment was sliced into 
50 segments from the cortical shell 
in a region approximately 0.5 mm 
above the most proximal portion of 
the growth plate. From the images, 
the following three-dimensional 
bone volume parameters were calcu-
lated: trabecular bone volume frac-
tion (BV/TV), trabecular thickness 
(Tb.Th), trabecular number (Tb.N) 
and trabecular separation (Tb.Sp). 
The trabecular bone compartment 
and the cortical bone sections were 
assessed. Following data extraction, 
linear regressions using ANOVA 
with Tukey’s test were performed to 
compare groups. 
In this study, 63 female mice were 
used. The number of mice in each 
group, age, mice delivered in each 
litter, and time between litters were 
tracked for all mice and subsequently 
analyzed and recorded (Table). BV/
TV had decreased as pregnancies 
increased from one to five liters 
(Figure). Interestingly, mice with no 
pregnancies had a smaller trabecular 
bone BV/TV than mice with one 
pregnancy (Figure). All groups showed 
statistically significant differences 
from the mice with one litter (p<0.05). 
Trabecular number decreased as 
number of litters increased (from one 
to five litters). Mice that had one litter 
had significantly higher Tb.N than 
other groups, including mice with no 
pregnancies. Analysis of trabecular 
thickness and spacing revealed no 
significant difference with respect to 
number of pregnancies. With respect 
to cortical bone analysis, no differ-
ences were found in BV/TV or in cor-
tical bone area. No differences were 
observed in cortical bone porosity. 
When analyzing the trabecular 
bone of mice in this study, a correla-
tion was observed between parity and 
bone density. As the number of litters 
increased (from one to five litters), 
measurements of trabecular bone in 
BV/TV and Tb.N both decreased. 
These results may suggest that more 
trabecular bone is broken down as 
number of pregnancies increases. 
However, while Tb.N decreased, 
there was no correlation seen in the 
width or spacing of the rods and plates 
that make up trabecular bone. There 
were also no significant differences 
in tissue mineral density or cortical 
 Continued on p. 12
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avg time to 
first litter 
(days)
avg time to 
last litter 
(days)
1 6 283±27 6.5 ±3.5 137 ±0 137 ±0
2 5 295 ±22 7.8 ±1.3 114 ±34 155 ±35
3 29 218 ±23 7.6 ±2.0 94 ±29 219 ±44
4 13 339 ±31 6.3 ±1.3 89 ±22 272 ±39
5 2 355 ±35 8.0 ±0.3 74 ±6 283 ±24
*avg = average
TABLE: Number of total litters, average age, mice per litter, age at birth of first litter, 
and age at birth of last litter
Alterations to Maternal Cortical and Trabecular Bone in 
Multiparous Middle-Aged Mice
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bone parameters. Taken together, 
these data sets suggest that parity in 
mice affects trabecular bone, but does 
not impact cortical bone or the total 
density of the bone. Furthermore, it 
seems increasingly likely that there are 
additional compensatory mechanisms 
at play to preserve bone health. These 
observations are supportive of a pre-
vious claim of the presence of cortical 
bone compensation in multiparous 
mice to offset an increased risk of post-
menopausal bone fracture.2 However, 
additional studies are required in order 
to further elucidate the presence of 
cortical bone compensation.
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Preimplantation genetic screening 
( PGS ) w it h euploid bl a stoc y st 
transfer has facilitated the selec-
tion of embryos most suitable for 
replacement and the optimization of 
IVF outcomes.1 Non-invasive deter-
minants of embryonic competence 
could be used independently or in 
conjunction with pre-implantation 
genetic screening (PGS) for embryo 
selection.2,3 Promising methods for 
evaluating embryonic implantation 
potential include the evaluation of 
substrates or byproducts of embryo 
metabolism, such as metabolite utili-
zation and the assessment of secreted 
proteins or metabolites in spent 
embryo culture media (secretome).4,5 
Using tandem mass spectrometry 
 Continued on p. 13
FIGURE: Effect of number of litters on (A) Trabecular BV/TV, (B) Trabecular thickness, 
(C) Trabecular number, and (D)  Trabecular separation. Bars represent mean ± standard 
deviation, * indicates statistically significant difference (p<0.05) compared with 1 litter. 
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TABLE 2: Albumin composition of analyzed media samples
abundance of proteins were deter-
mined by comparing the number of 
peptides identified per protein across 
all samples (spectral counting). 
Albumin and high abundant pro-
teins were successfully depleted 
from the embryo culture media, as 
evidenced by the low peptide-to-
spectrum matches (PSM) of albumin 
after the Multiple Affinity Removal 
System protocol. There were no signif-
icant differences in the secretome of 
spent embryo culture media between 
control samples and those in which 
embryos were cultured (Table 2). This 
may be a limitation related to deple-
tion of albumin and associated bound 
proteins.
The use of a Multiple Affinity 
Removal System protocol resulted in 
successful depletion of albumin and 
high abundant proteins in embryo cul-
ture media, which may facilitate the 
detection of low abundance proteins. 
After albumin depletion, no differ-
ences in the secretome between con-
trol and sample embryo culture media 
droplets were detected. Further vali-
dation studies are underway to refine 
the technique and subsequently move 
forward with this pivotal clinical trial. 
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Supported by a grant from the Foundation for 
Embryonic Competence
(MS), we sought to investigate the 
embryonic secretome in spent embryo 
culture media in relation to embryo 
development and quality. After vali-
dation of the technique, the embry-
onic secretome in relation to aneu-
ploidy and in vitro fertilization (IVF) 
outcomes will be investigated through 
a prospective cohort study.
Patients undergoing IVF with 
c o m p r e h e n s i v e  c h r o m o s o m e 
screening (CCS) at Shady Grove 
Fertility Center were eligible to 
participate. From fertilization until 
Day 3 of development, embr yos 
were cultured in Continuous Single 
Culture Medium (Irvine Scientific) 
supplemented with Serum Protein 
Substitute (Origio). From Day 3 of 
development until the blastocyst 
stage (Day 5 or 6), embryos were cul-
tured in Blastocyst Medium supple-
mented with human serum albumin 
(Origio). Embryos were co-cultured 
in groups of three or four from fertil-
ization until the blastocyst stage was 
obtained (Table 1). An immunoaf-
finity depletion strategy was used to 
deplete high abundant serum proteins 
(i.e. albumin) from media samples. 
The remaining proteins secreted into 
the media were digested with trypsin 
using pressure cycling technology 
and peptide digests were analyzed 
by nanoflow liquid chromatography 
(LC) coupled with a high-resolution 
Orbitrap Fusion Lumos mass spec-
trometer. Tandem mass spectra were 
searched against a SwissProt human 
protein database and the relative 
 Continued from p. 12
Well 1,  
Day 3 Sample
Well 1,  
Day 3 Control
Well 3,  
Day 5 Sample
Well 3,  
Day 5 Control
Total PSMs 1,701 787 1,101 1,796
Total Proteins 273 195 133 230
Proteins 2+ 
PSMs
158 90 76 125
Albumin (PSM) 24 16 3 15
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TABLE 1: Summation of Measured Variables by Study
Efficacy of Manipulation Under Anesthesia for Stiffness 
Following Total Knee Arthroplasty: A Systematic Review
Knee stiffness following primary total 
knee arthroplasty (TKA) can lead 
to unsatisfactory patient outcomes, 
including failure to meet the target 
functional outcomes for the proce-
dure.1,2 Stiffness is characterized by 
limited range of motion (ROM), fre-
quently associated with pain and knee 
dysfunction. Manipulation under 
anesthesia (MUA) remains a viable 
option for treatment of post-operative 
stiffness. However, the efficacy and 
optimal timing of manipulation of 
anesthesia remains unknown.
A systematic review of the litera-
ture was performed to identify studies 
that reported clinical outcomes for 
patients who underwent MUA for 
post-operative stiffness treatment. 
The search resulted in 727 abstracts 
that were examined to determine 
the efficacy of MUA for stiffness 
post-TKA. Following elimination 
of duplicate articles, predetermined 
inclusion and exclusion criteria were 
applied. In total, 24 articles met the 
inclusion criteria. Of these 24 articles, 
three papers were excluded due to 
incomplete data.
Twenty one studies reported data 
on primary MUA outcomes in over 
1,300 total patients (Table 1). The 
mean sample patient population size 
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Based on available data from 17 papers, 
the mean prevalence of patients that 
underwent MUA after TKA was 5.8% 
(Table 1). The time between TKA 
and MUA was provided in 15 studies 
and ranged from two weeks to 22 
weeks with an aggregate mean of 9.9 
weeks (Table 1). The mean pre-TKA 
motion and/or f lexion was greater 
than 100 degrees in all reporting 
studies except Fox et al., Bawa et al., 
and Yeoh et al., who reported popula-
tions that had a pre-TKA flexion of 
96, 96.5, and 93 degrees, respectively 
(Table 1). Post-MUA, a mean ROM 
of greater than 90 degrees at final 
follow up was achieved in all studies 
except two (Table 1). The time at 
which final ROM measurements 
were recorded varied from six weeks 
to seven and a half years, with a mean 
follow-up time of 32 months across all 
reporting studies (Table 2; Table 1). 
There was significant improvement 
in f lexion or total range of motion 
post-MUA versus pre-MUA in all 
reported studies (p < 0.05) (Table 1). 
Several studies commented on the 
effect of latency between TKA and 
primary MUA on outcomes. The most 
common time point used to evaluate 
this outcome was approximately three 
months (Table 2). Six of the 21 studies 
reported a complication associated 
with the primary MUA procedure, 
yielding a complication rate of less 
than 1% (Table 1).
MUA remains an efficacious, 
low-risk, and minimally invasive 
treatment option for post-operative 
stiffness following TKA. Compared 
 Continued on p. 15
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TABLE 2: Timing’s effect on Primary MUA Motion Outcomes
to before MUA, our study found a 
mean overall gain in f lexion of 32.1 
degrees and an overall gain of 35.8 
degrees of ROM after MUA (Table 1). 
Based on the included data comparing 
cohorts undergoing MUA at various 
time points, our study indicates that 
MUA should be performed between 
four and 12 weeks (Table 2). Without 
significant evidence of greater ben-
efit before four weeks, conservative 
management of stiffness warrants an 
adequate trial. Four to 12 weeks is an 
optimal time for intervention because 
it balances the need to attempt conser-
vative management with the greater 
effect size for improved flexion/ROM 
after MUA within this period. In 
summary, MUA provides clinically 
significant improvement in ROM for 
most patients, with the best outcomes 
occurring in patients treated during 
the four to 12 weeks post-TKA period. 
REFERENCES 
1. Kim J, Nelson CL, Lotke PA. Stiffness after 
total knee arthroplasty: Prevalence of 
the complication and outcomes of revi-
sion. Journal of Bone and Joint Surgery. 
2004;86:1479-1484.
 Continued from p. 14
2. Diduch DR, Scuderi GR, Scott WN, Insall JN, 
Kelly MA. The efficacy of arthroscopy fol-
lowing total knee replacement. Arthros-
copy: The Journal of Arthroscopic and 
Related Surgery. 1997;13(2):166-171.
16 Fusion ♦ 2018
Ketamine, an NMDA (N-methyl-D-
aspartate) antagonist, has been shown 
to be an effective treatment option for 
pain management1. Previous studies 
have shown improvement in outcomes 
in chronic pain patients following 
ketamine infusions.2,3 Chronic pain 
is determined in a temporal fashion, 
with an arbitrary timeframe of three 
to six months, and may be subdivided 
into nociceptive, inflammatory, neu-
ropathic and dysfunctional categories 
of pain. In our previous study patients 
with chronic pain, unresponsive to 
conventional treatment, demon-
strated improved outcomes with 
outpatient ketamine infusions.4 The 
purpose of this study is to examine the 
efficacy of outpatient ketamine infu-
sions in patients with various chronic 
pain conditions.
After IRB approval we examined 
data on patients undergoing outpa-
tient ketamine infusions. We subdi-
vided patients based on their chronic 
pain diagnosis into four nonexclusive 
categories: neuropathic pain, gener-
alized pain, chronic postoperative 
pain, and chronic pain in patients 
with a psychiatric diagnosis. Patients 
completed the Brief Pain Inventory 
(BPI) prior to one-day or three-day 
outpatient ketamine infusions and 
again two to four weeks after the infu-
sions. We measured pain scores and 
outcomes related to general activity, 
mood, walking ability, normal work, 
relations with other people, sleep, and 
enjoyment of life.
For data analysis, a random effects 
mixed model was used to test the 
time effect (pre versus post) for pain 
and other outcomes, as well as the 
diagnosis by time interaction. This 
method accounted for within-subject 
autocorrelation of the pain scores.
There were 224 patients in the 
sample: 143 patients with neuropathic 
pain (64%), 49 with generalized pain 
(22%), 80 with chronic post-op pain 
(36%), and 63 with psychiatric diag-
noses in addition to chronic pain 
(28%). There was a significant drop in 
mean pain level from pre- to post-infu-
sion (p<0.0001) for all diagnoses, with 
the mean pain level dropping from 7.6 
(95% confidence interval 6.8 to 8.5) to 
6.8 (95% ci 6.0 to 7.7) after adjusting for 
covariates. The decreases in pain relief 
among the different groups were not 
significantly different (Figure).
General activity significantly 
improved in patients with chronic 
post-op pain (p=0.0062) and in those 
with psychiatric diagnosis (p=0.0044). 
Walking improved signif icantly 
in those without chronic post-op 
pain (p=0.025). Work impairment 
was significantly less in those with 
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Efficacy of Outpatient Ketamine Infusions on  
Different Etiologies of Chronic Pain
FIGURE: Changes in Mean Pain Score Pre and Post Outpatient Ketamine Infusion
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FIGURE: Effect of tetrathiomolybdate on patients at a high risk for recurrence. 
A) Reduction in VEGFR2+ EPCs using a mixed-effects model (P= 0.004); B) Lysy1 oxidase 
2 (LOXL-2) were markedly reduced at 12 and 24 months (P<0.001). Both VEGFR2+ EPCs 
and LOX condition the pre-metastatic niche and create a permissive environment for 
tumor metastases. 
neuropathic pain (p=0.01) and in 
those without psychiatric diagnosis 
(p=0.44). Sleep impairment was sig-
nificantly less in those without chronic 
post-op pain (p=0.16).
Outpatient ketamine infusions 
significantly improved pain scores in 
patients with the following chronic 
pain conditions: neuropathic, general-
ized, chronic post-op pain, and chronic 
pain in patients with psychiatric 
 Continued from p. 16 diagnosis. Closer analysis shows that 
improvement in various quality of life 
measures differed significantly among 
different chronic pain conditions. 
Further study with larger sample 
groups may help elucidate ketamine’s 
broad therapeutic effect as interest in 
this drug’s potential for therapy of a 
multitude of chronic pain conditions 
increases. 
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Metals have emerged as a viable 
therapeutic target for a new genera-
tion of anti-cancer and anti-metastatic 
agents. Copper, an essential trace ele-
ment, serves as an important catalytic 
cofactor in several biological functions 
and has emerged as an essential factor 
in carcinogenesis.1 It is well estab-
lished in preclinical mouse models 
of breast cancer progression that the 
pre-metastatic niche depends on bone 
marrow (BM) derived VEGFR2+ 
endothelial progenitor cells (EPCs) 
and copper-dependent lysyl oxidase 
(LOX), among other elements, to 
create a hospitable microenvironment 
that supports tumor progression.2,3 
Prior clinical trials have shown the 
efficacy of tetrathiomolybdate (TM), 
an oral copper chelator, to reduce 
serum ceruloplasmin (Cp) levels 
while being safe and well-tolerated 
in advanced cancer patients.4 We 
hypothesized that TM-associated 
copper depletion (CD) inhibits tumor 
metastases by reducing the number 
of EPCs and other copper dependent 
processes in the pre-metastatic niche. 
These results are an update of our 
previously reported study with longer 
follow-up.5  
A single arm phase II study of CD 
with TM enrolled breast cancer (BC) 
patients who are at high risk for cancer 
recurrence post-treatment, including 
those who had node+ triple negative 
(TNBC), Stage 3, and Stage 4 BC with 
no evidence of disease (NED). TM was 
given to maintain ceruloplasmin levels 









Kettering Cancer Center, New York, New York
A Phase II Study of Copper-Depletion Using 
Tetrathiomolybdate in Patients with Breast Cancer at  
High Risk for Recurrence: Updated Results
18 Fusion ♦ 2018
between 8-16 mg/dl for two years with 
an extension phase or until relapse. 
The primary endpoint was change 
in EPCs measured by f low cytom-
etry before and during treatment. 
Secondary endpoints included toler-
ability, safety, PFS and LOXL-2 levels. 
Seventy-five patients received 
2,778 cycles of TM in the primary and 
extension study. The primary study 
treatment duration was 24 cycles 
(each cycle is 28 days) plus an exten-
sion phase. The median age is 51 years 
(range 29–66). Forty-five patients 
have stage 2/3 BC, and 30 have Stage 4 
BC with NED. Forty-eight percent 
of patients have TNBC and 40% of 
patients have Stage 4 NED. Median 
serum Cp levels were monitored with 
each cycle. After one cycle, there 
was a decrease in Cp from 28 to 16 
(p<0.0001). Interestingly, TNBC 
seemed to have a greater decrease 
from 23.5 to 13 after one cycle. TM was 
well tolerated, with grade 3/4 toxici-
ties including: reversible neutropenia 
(2.3%), febrile neutropenia (0.04%), 
and fatigue (0.2%). Five-year analysis 
showed a decrease in EPC’s (p=0.004) 
and LOXL-2 (p<0.001) compared to 
baseline (Figure 1). At a median follow-
up of 7.1 years, the event free survival 
(EFS) for 75 patients is 71.4%. The EFS 
for 36 patients with TNBC is 71.7%. 
EFS for Stage 2/3 TNBC is 83% and for 
stage IV TNBC is 59.3%. The overall 
survival for TNBC patients is 80%.  
TM is safe, well-tolerated and 
appears to affect multiple components 
of the tumor microenvironment iden-
tified in pre-clinical models as impor-
tant for progression. Ongoing studies 
in banked specimens are underway to 
further delineate its effect on copper 
dependent processes necessary for 
metastases. Randomized trials are 
warranted, especially in patients who 
are at high risk for relapse, such as 
those with TNBC.
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Weight loss surgery is becoming an 
increasingly utilized treatment option 
for adolescents with severe obesity. 
However, there is still limited research 
on weight loss outcomes for a wide 
range of patients. Therefore, the cur-
rent study aims to investigate the effect 
of demographic variables (i.e., age, 
gender, and ethnicity) and pre-surgical 
mental health on the change in body 
mass index (BMI) after Laparoscopic 
Sleeve Gastrectomy (LSG) in the first 
year following surgery. 
This is a retrospective medical 
chart review of a prospective database 
of patients who underwent LSG. In 
this study, N= 196, 75% of patients 
were female, and their average age 
was 17 with a standard deviation of 
2.45, but ranged from 6-22. Minorities 
made up 75% of the patient popula-
tion. The average pre-op BMI of 
the group was 50.99 with a standard 
deviation of 8.67. The mean percent 
excess BMI lost at 12 months was 
53.9% with a standard deviation 
of 23.7%. Of the 196 patients, 165 
patients had pre-surgical mental 
health evaluations. Of these 165, 28.5% 
had an anxiety disorder, 46.5% had 
a depressive/mood disorder, 21.8% 
had ADHD, and 10.3% had an eating 
disorder. Change in BMI at three 
months, six months and 12 months 
post-op was assessed at post-surgical 
follow up visits. Demographic vari-
ables and mental health diagnoses, 
evaluated using a structured interview 
(KSADS), were obtained at the pre-
surgical psychological evaluation. 
 Continued on p. 19
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A non-linear Latent Variable 
Growth Model (LGM) was estimated, 
including demographic variables and 
presence/absence of diagnoses in the 
classes of anxiety, depression, atten-
tional disorders, and eating disorders.
The LGM model showed that 
change per three months was statis-
tically significant (r=2.247, P<0.001). 
Weight loss at three months was 
significantly associated with weight 
loss at 12 months (r=0.892, P<0.001). 
However, the standardized effect 
was larger in a model where the 
latent intercept factor represents 
the six month outcomes (I=0.650), 
compared to where “I” represents the 
three month outcomes (I=0.516). This 
indicates weight loss at six months had 
a larger influence than weight loss at 
three months on the weight loss at 12 
months. Age, gender, and ethnicity 
were not associated with three month 
or 12 month weight loss, or in the 
rate of weight loss. The presence of 
a diagnosis of anxiety, depression, 
or ADHD was not associated with 
weight loss at any time. However, the 
presence of a diagnosed eating dis-
order was associated with less weight 
loss at three months.
Results of this study indicate that 
there is no association of demographic 
variables or most mental health diag-
noses with weight loss outcomes fol-
lowing LSG in adolescents. The lack of 
a difference in the effect of age serves 
to mitigate the argument that LSG is 
not as effective in adolescents under 
the age of 18 as it is in those over 18. 
Moreover, presence of a mental health 
diagnosis should not serve as a contra-
indication to surgery, but assessment 
and treatment of disordered eating 
should remain an important part of 
preparation for surgery.
Also, the larger effect of the six 
month change in BMI (as compared 
to that of  three month change in 
BMI) on the 12 month outcome sug-
gests there may be a window in which 
patients exhibiting suboptimal BMI 
change at three months can be identi-
fied and an intervention provided to 
optimize % excess BMI loss.
 Continued from p. 18
Single nucleotide polymorphisms 
(SNPs) are associated with differential 
bone mineral density (BMD) measures 
in humans. Oxidative stress has been 
implicated in negatively impacting 
bone qua l it y. T he Glutath ione 
S-transferase P 1 (GSTP1) family of 
enzymes minimize oxidative cellular 
damage. Studies have shown that vari-
ation at rs1695 in GSTP1 negatively 
impacts BMD.1,2 Another determinant 
in bone quality is the canonical-Wnt 
pathway, in which the AXIN1 protein 
functions as a negative regulator. A 
2015 study implicated the rs9921222 
variant of AXIN1 as having significant 
associations with lower total BMD 
and osteoporosis.3 The present study 
sought to expand our understanding 
of the influence of genetic variation 
in GTSP1 and AXIN1.
Previously assembled DNA sam-
ples from The Bone Health cohort 
(African-American, n=87; 46 male, 
41 female; ages 5–9) and a Caucasian 
sub-cohort of the Assessing Inherited 
Markers of Metabolic Syndrome in the 
Young (AIMMY) (n=209; 102 males, 
107 females; ages 18-35) were utilized 
to measure total BMD without head 
z-score (adjusted for height) and total 
BMD, respectively. An Illumina 
Multi-Ethnic Genotyping Array 
(MEGA) chip was utilized to geno-
type the Bone Health cohort, while 
the Applied Biosystems Taqman 
allelic discrimination assays/Applied 
Biosystems 7900 HT Real-Time PCR 
were utilized for the AIMMY cohort. 
Analysis of covariance (ANCOVA) 
models where genoty pe was the 
dependent variable, appropriate phe-
notype the independent variable, 
and age (for Bone Health), or age and 
height (for AIMMY), as covariates 
were utilized to analyze for genotype-
phenotype associations.
A statistically significant associa-
tion between total BMD and rs1695 
was observed in males of the AIMMY 
Caucasian cohort (p=0.047). No sig-
nificant association between the 
homozygous GG variant of rs1695 and 
total BMD was found. No statistically 
significant genotype-phenotype asso-
ciations between rs9921222 or rs1695 
and total BMD were present in the 
Bone Health cohort using an additive 
genetic model. There was no reported 
 Continued on p. 20
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Opioid prescriptions in the United 
States have more than tripled from 
1999–2014, during which there has 
been a staggering increase in opioid-
involved dr ug overdose deaths.1 
Physician prescribing patterns are 
thought to be a major contributory 
factor to the increase in drug overdose 
in America, as four out of five new 
heroin users started by misusing pre-
scription painkillers.2 Providers need 
the means to objectively monitor anal-
gesic efficacy of treatment in patients 
with pain to mitigate unnecessary 
analgesic prescriptions.  
 Continued on p. 21
association between total BMD and 
the rs1695 GG homozygote variant. 
This study found a significant asso-
ciation of total BMD and rs1695 AG 
variant in males from the Caucasian 
subset of  t he A I M M Y cohor t 
(p=0.047). Of note, the homozygous 
GG minor allele did not demon-
strate a significant association with 
total BMD, despite previous studies 
reporting otherwise. Significant dif-
ferences in the association of genetic 
variants of rs1695 and BMD in both 
the AIMMY and Bone Health cohorts 
could be influenced by race/ethnicity 
— both of which have been signifi-
cantly associated with bone quality/
fracture risk. The significant associa-
tion present in Caucasian males of the 
AIMMY cohort (p=0.047) but not 
in females (p = 0.33) underscores the 
 Continued from p. 19 important role of sexual dimorphism 
in determining musculoskeletal phe-
notypes. The presence of the rs1695 G 
allele variant in GSTP1 could indicate 
appreciable build-up of ROS in males 
and lower quality of bone.
In contrast to previous studies, 
our work did not find a significant 
association with rs9921222 and total 
BMD or BMD z-score minus head. 
Conflicting results could be attributed 
to differences in sample size and demo-
graphics, but the highly polygenic 
nature of BMD makes this a more 
complicated issue. It is plausible that 
rs9921222 may be associated with lower 
total BMD in previous studies because 
it is in linkage disequilibrium, or 
inherited with other SNPs associated 
with lower BMD. The present study 
could not account for confounding 
SNPs that may have been inherited 
along with rs9921222. Future studies 
may be able to analyze linkage disequi-
librium when establishing associations 
between rs9921222 and total BMD. 
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FIGURE: PLR of a patient on PCA opioid pain control. Normal opioid induced 


























It is well established that mu 
opioid agonists like morphine cause 
miosis, an effect that does not exhibit 
tolerance.3 This suggests utility in 
investigating pupil size and respon-
siveness as pharmacokinetic measures 
of bioavailability. An infrared pupil-
lometer is a device that produces a 
short light stimulus and subsequently 
measures parameters of the pupil-
lary light ref lex (PLR) including 
maximum and minimum pupil size 
(MAX, MIN), maximum constriction 
velocity (MCV), latency period before 
constriction onset (LAT), change in 
pupil size (DELTA), and average con-
striction velocity (ACV). Current data 
support the efficacy of using infrared 
pupillometry to detect high dose 
opioid presence, but no research exists 
judging its efficacy in monitoring 
low dose therapeutic levels.4 Patient 
controlled analgesia (PCA) is widely 
used for pediatric inpatients due to 
advantages associated with patient 
autonomy through self-administration 
and maintenance of steady state, as 
the dose for each pump is low and is 
equipped with a max-out setting.5
In our IRB approved study, we 
enrolled 15 patients between the ages 
of 7 and 18 on the pain medicine service 
receiving low dose morphine (n=12) or 
hydromorphone (n=3) on PCA. The 
patients were either post-surgical or 
admitted for sickle cell vasoocclusive 
crisis. The pupillometer was used to 
take a baseline PLR (Figure 1), and 
repeated measures were taken 10 
and 15 minutes post-PCA dose infu-
sion, which was administered at the 
patient’s discretion.
A repeated measures ANOVA 
using GraphPad Prism version 7.00c 
was conducted to compare the effect 
of the opioid on specific parameters 
of the PLR. There was a significant 
effect of the opioid on the MAX, 
MIN, LAT and MCV parameters 
(Table 1). Post hoc tests found that 
the 10 and 15 minute time points were 
significantly smaller than the baseline 
for the parameters MAX (p=.0016, 
p=.0010) and MIN (p=.0250, p=.0070). 
Additionally, it was found that LAT 
was significantly longer from baseline 
at the 15-minute measure (p=.0350), 
and there was a significant difference 
between the 10 and 15 minute time 
points for the MIN (p=0.0251). 
This evidence supports the use of 
the pupillometer in evaluating opioid 
pharmacologic activity and patient 
sensitivity. Furthermore, in concor-
dance with previous research, the 
MIN is significantly correlated with 
opioid concentration dose-depend-
ently across the 15-minute measure-
ment window. Before applying the 
pupillometer to clinical pain medi-
cine, more research needs to be done 
comparing pupillometric parameters 
to blood levels of opioid metabolites. 
With detection limits, providers 
could use this tool to monitor treat-
ment efficacy and optimize opioid 
administration schedules based on 
patient physiology, rate of metabolism, 
and previous opioid use. One spe-
cific application could eliminate the 
need for genetic testing for CYP2D6 
polymorphisms, instead using the 
pupillometer to assess pharmaco-
logic activity following a small dose. 
Developing noninvasive ways to objec-
tively measure the effects of opioid 
medications will help clinicians more 
responsibly prescribe these drugs that 
have been so widely abused over the 
last 20 years.
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TABLE: Repeated Measires ANOVA evaluating the significance of all pupillary 
parameters baseline vs. post-PCA dosing
Effect DFn, Dfd F Statistic p-Value R2
MAX (Maximum Pupil Size) 1.222, 17.11 11.68 0.0021 0.4548
MIN (Minimum Pupil Size) 1.211, 16.95 10.3 0.0036 0.4239
DELTA (Change in Pupil Size) 1.442, 20.18 1.775 0.1989 0.1125
LAT (Latency period before onset of 
constriction)
1.882, 26.35 3.746 0.0393 0.2111
ACV (Average Constriction Velocity) 1.764, 24.7 2.326 0.1239 0.7908
MCV (Maximum Constriction 
Velocity)
1.934, 27.08 3.414 0.0490 0.1961
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Bowel and Bladder Dysfunction 
(BBD) refers to a heterogenous group 
of voiding disorders, accounting for 
an estimated 40 percent of pediatric 
urology visits.1 Symptoms of BBD 
include enuresis, urgency, and uri-
nary retention, often accompanied 
by constipation. While the role of the 
autonomic nervous system (ANS) in 
regulation of voiding is well-charac-
terized, it is not known if children 
presenting with BBD exhibit distinct 
patterns of ANS activity that could be 
measured for diagnosis or targeted for 
intervention. 
Pupillometry allows for assessment 
of systemic ANS activity, and there-
fore could elucidate differences in ANS 
function among BBD patients. This 
study aimed to determine whether a 
pupillary response can be character-
ized for BBD. Eight pupillary light 
reflex (PLR) parameters were assessed 
and compared to controls. 
The goal of this study was to use 
pupillometry to compare the pupillary 
responses of BBD patients to controls 
pre- and post-voiding. Hypotheses 
were:
 ➤ 1.  BBD patients will show a 
distinct pattern of ANS activity 
relative to controls. 
 ➤ 2.  BBD patients will show dif-
ferent changes in ANS activity 
before and after voiding relative 
to controls.
T he Ne u ropt ics  PL R- 2 0 0 0 
pupilometer was used to assess 
eight pupillary parameters. Both 
BBD patients and controls were 
recruited from the urology clinic at 
Children’s National. Using scores 
from the Dysfunctional Voiding and 
Incontinence Scoring System (DVISS) 
questionnaire, subjects were identified 
as BBD patients (score of 9 or higher; 
n=10) or control patients (score of 8 or 
lower; n=8). Pupillometry was then 
conducted before and after voiding. 
B B D  p a t i e n t s  s h o w e d  a 
significantly larger maximum pupil 
size in the pre-voiding condition 
rel at i ve  to cont rol s  ( Ta ble  1). 
Additionally, several pre- and post-
voiding parameters showed near-
significant differences. The changes 
in values pre- and post-voiding were 
also compared, and BBD patients 
showed significantly larger changes 
in both minimum pupil size and in 
average constriction velocity (ACV) 
(Table 2). These results suggest that 
BBD patients may have a distinctive 
profile of ANS activity, and that this 
profile may be detectable in a clinical 
setting via pupillometry. 
The role of the autonomic nervous 
system in voiding behavior is well 
described, with the parasympathetic 
ner vous system ( PNS) general ly 
more active during voiding, and the 
sympathetic nervous system (SNS) 
more active during the retention 
phase in healthy patients.
The larger maximum pupil size 
seen in the pre-voiding condition 
among BBD patients could indicate 
higher SNS activity, or lower PNS 
activity, during the retention phase. 
This is consistent with a finding from 
a study of cardiac autonomic activity 
among BBD patients, which found 
higher baseline heart rates relative 
to controls, consistent with relatively 
higher SNS activity.1
Additionally, the significantly 
larger changes in minimum pupil 
size and average constriction velocity 
bet ween pre- a nd post-void i ng 
conditions among BBD patients could 
indicate greater variability in ANS 
activity related to voiding behavior. 
The results could be applied toward 
a diagnostic tool for identify patients 
with BBD dysautonomia, versus 
patients with behavioral, anatomical, 
or other causes of urinary symptoms. 
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TABLE 1: P-values from T-tests of pupillary parameters among BBD patients 
compared to controls.
MAX MIN DELTA LAT ACV MCV ADV
Pre-
voiding
0.035395 0.098949 0.342316 0.331814 0.056367 0.139481 0.175263
Post-
voiding
0.069649 0.178029 0.224430 0.096806 0.256561 0.120460 0.310756
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Extensive variation in skeletal muscle 
strength has been attributed to a 
combination of genetic and environ-
mental factors. Recent studies show 
that favorable single nucleotide poly-
morphisms (SNPs) in PPARGC1A 
and Insulin-like Growth Factor 1 
(IGF-1) genes correlate with greater 
power sport performance in profes-
sional athletes.1,2 In rs8192678 on the 
PPARGC1A gene, a substitution of 
adenine (A) for guanine (G) causes 
serine (Ser) to replace glycine (Gly) 
resulting in lower PGC-1α expression 
and reduced performance.1 For an 
IGF-1 rs7136446 polymorphism, GG 
homozygosity correlates with greater 
expression of IGF-1 and increased 
maximal force.3 The purpose of the 
study was to investigate whether these 
polymorphisms predict strength per-
formance in young Caucasian adults 
who are not elite athletes.
Functional Single Nucleotide 
Poly mor phism Associated w ith 
Human Muscle Size and Strength 
(FAMuSS) consisted of healthy young 
adult Caucasians who participated 
 Continued on p. 24
TABLE 2: P-values from T-tests of change in pupillary parameters post-voiding among 
BBD patients compared to controls. Max = maximum pupillary diameter; MIN = 
minimum pupillary diamter; DELTA = change in pupillary diameter; LAT = latency; ACV = 
average constriction velocity; MCV = maximum contriction velocity; and ADV = average 
dilation velocity.
MAX MIN DELTA LAT ACV MCV ADV
0.126567 0.015353 0.159828 0.097724 0.042967 0.482969 0.133028
PPARGC1A and IGF Polymorphisms Correlate with Greater 
Strength Performance in Healthy Young Adult Caucasian 
Cohorts
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MSII 






School of Medicine and Health Sciences 
2 Center of Genetic Medicine, Children’s 
National Health System, Washington, D.C.
TABLE 1: Significant genotype / phenotype association found in FAMuSS; Additive 
model
SNP Phenotype Gender N; adjusted mean ± SEM Significantly 
different 
genotypes
PPARGC1A % change 
in 1-RM 
strength (D)
Female GG (N=171; 11.69 ± 3.06)*  
AG (N=210; 13.35 ± 2.76)** 






Male GG (N=136; 29.89 ± 0.52)*  
AG (N=162; 28.91 ± 0.47)   








Female AA (N=94; 58.25 ± 2.29)*  
GA (N=122; 67.00 ± 2.02)*  







Female AA (N=94; 61.34 ± 2.33)*  
GA (N=122; 69.58 ± 2.05)*  







Male AA (N=61; 20.01 ± 2.55)   
GA (N=66; 15.92 ± 2.44)*  







Male AA (N=60; 6.79 ± 2.04)   
GA (N=65; 2.39 ± 1.95)*   
GG (N=34; 12.09 ± 2.71)*
*p=0.0125
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TABLE 2: Significant genotype / phenotype associations found in AIMMY (Caucasian 
subcohort); Additive model





Height Males TT (N=34; 178.69 ± 1.17)   
CT (N=29; 183.08 ± 1.27)*  
CC (N=9; 178.89 ± 2.27)
*p=0.0388
in a three-month strengthening pro-
gram of their non-dominant (ND) 
arm (males: n=165, females: n=276, 
avg. age= 23 years). Baseline strength 
and percent change in strength 
after training were measured. The 
Assessing Inherited Markers of 
Metabolic Syndrome in the Young 
(AIMMY ) University of Calgary 
Caucasian sub-cohort was composed 
of young adults (male n= 102, female n= 
107, avg. age= 23 years). Grip strength 
and oxygen consumption (VO2 Max) 
were measured. Allele frequencies 
were calculated and tested, and out-
comes were separated by sex using 
analysis of covariance. Where the 
overall ANCOVA F-test was statisti-
cally significant, post hoc pair-wise 
comparisons were performed and 
the p-values were adjusted using the 
Sidak method.  
FA MuSS Genot y pe distribu-
tions for PPARGC1A were found 
to be in Hardy-Weinberg equilib-
rium. Although IGF-1 was not in 
Hardy Weinberg equilibrium, the 
distribution of alleles was similar to 
a prior study of IGF1 gene variants4 
and was not excluded. AIMMY: 
Genotype distributions for IGF-I 
and PPARGC1A were found to be in 
Hardy-Weinberg equilibrium.  
Our study expands our under-
standing of the roles rs8192678 and 
rs7136446 play in anaerobic exercises. 
Previous research of PPARGC1A 
in endurance athletes found a lower 
frequency of the Ser allele correlates 
with greater aerobic performance, 
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but that the Ser/Ser genotype was 
more common among powerlifter 
athletes.1 We found that while Ser/
Ser genotype females had a greater 
percentage change in 1-RM strength 
in the D arm, there was no statistically 
significance of the Ser/Ser genotype 
regarding baseline strength, per-
centage change in 1-RM strength of 
the ND arm, or percentage change 
of isometric strength. In male partici-
pants, the Gly/Gly genotype was more 
beneficial to baseline 1-RM strength. 
Our study found no significant asso-
ciations for variants of rs8192678 
with VO2 max. The results indicate 
a potential sexually dimorphic effect. 
Genetic variants resulting in 
higher expression of IGF-1 have been 
associated with greater muscular 
strength responses to anaerobic 
training as well as greater aerobic 
performance2. We focused on genetic 
variation in rs7136446 impacted 
strength and anaerobic exercise. We 
found that male G/G individuals had 
a greater percent change in isometric 
strength than heterozygous indi-
viduals. Females with at least one G 
allele had a greater baseline isometric 
strength and VO2 ma. Our results 
support earlier findings of correlation 
with greater maximal force produc-
tion3 and indicate a sexually dimor-
phic effect.
Va r i at ion i n  r s 8192 6 78 a nd 
rs7136446 may help predict individual 
response to an exercise program, 
particularly in females. The ability 
to better predict response would play 
a significant role when choosing more 
effective exercise and physical therapy 
programs.  
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Congenital heart disease (CHD) is 
the most common birth defect1 with 
an incidence of 1%, or about 40,000, 
births per year.3 Patients with CHD 
are at increased risk of cardiac arrest 
and mortality during anesthesia and 
surgery owing to several factors like 
anesthetic agents depressing cardiac 
function and reducing blood pres-
sure, which further impairs cardiac 
function. Many of these patients have 
Trisomy 21 and other syndromes that 
further complicate anesthetic care 
owing to difficult airway manage-
ment, difficult vascular access, and 
respiratory compromise. Due to these 
conditions, vigilance and attention to 
detail and the ability to react rapidly 
to physiologic changes is required 
throughout the course of anesthesia.5
Faraoni et. al in 2016 published a 
study further looking into post-oper-
ative outcomes in children with and 
without CHD undergoing non-cardiac 
surgery. Patients with major CHD had 
a mortality rate of 3.6% and those with 
severe CHD had a mortality rate of 
8.2%. They found that children with 
severe CHD had an increased risk of 
30-day morality with an odds ratio of 
8.43. They also found that major and 
severe CHD children also had higher 
rates of reintubation compared to non-
CHD patients with odds ratio of 3.11 
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and 2.46. Severe CHD children had 
higher cardiac arrest rates.
Children’s National Health System 
(Children’s National) has a special-
ized Cardiac Anesthesia division that 
specializes in the care of children 
with CHD. Patients with CHD who 
require surgery undergo thorough 
and comprehensive risk stratification 
by a pediatric cardiac anesthesiolo-
gist prior to any surgery. It includes a 
review of preoperative clinical data 
and preoperative medication manage-
ment, formulation of an appropriate 
anesthetic plan, and determination 
of postoperative disposition. Patients 
deemed moderate and high-risk are 
cared for by the cardiac anesthesia 
team, allowing highly specialized 
anesthesia care for complicated cases. 
We investigated the impact on 
care with the formation of the spe-
cialized Cardiac Anesthesia division 
on perioperative outcomes for non-
cardiac surgery. A retrospective study 
assessed the management of these 
CHD patients. A group of patients 
who had CHD and underwent non-
cardiac surgery were selected, and 
categorized according to the ACS 
NSQIP Pediatric Risk Calculator. 
For each patient, their intraoperative 
cardiac arrest rate, reintubation rate, 
and 30-day mortality were gathered 
and analyzed. 
Out of the 131 CHD patients under-
going non-cardiac surgery seen by 
the Cardiac Anesthesia division, 13 
had mild CHD, 58 had major CHD, 
and 58 had severe CHD. Within this 
patient population, there was an intra-
operative cardiac arrest rate of 0.8%, 
postoperative cardiac arrest rate of 
2.3%, reintubation rate of 3.9%, 30-day 
mortality of 1.8% among major CHD 
patients, and 30-day mortality among 
severe patients of 12%. 
The cardiac anesthesia team at 
Children’s National cared for a large 
number of major and severe CHD 
patients. The use of a specialized 
cardiac anesthesia team in the man-
agement of such complex patients 
led to a low incidence of periopera-
tive cardiac arrest and reintubation 
compared to other literature, such as 
Ramamoorthy’s study. Patients with 
severe CHD continued to have a high 
rate of 30-day mortality. The main 
limitation of this study is the lack of 
a true control group for comparison. 
While this study suggests that using 
a specialized team in the manage-
ment of complex high-risk cardiac 
patients leads to improved outcomes, 
a prospective study is needed for 
confirmation. 
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FIGURE 1: OCTA of chriocapillaris in A) normal, and B) AMD subjects. Age-related macular degeneration 
(AMD) is the leading cause of blind-
ness in people 55 years and older in 
developed countries. While the patho-
physiology of AMD has primarily 
been attributed to oxidative stress 
and inflammatory pathways, there is 
evidence of a vascular contribution to 
the disease pathogenesis, including 
choroidal hypoperfusion and chorio-
capillaris vascular density dropout. 
However, it is unknown if decreased 
choroidal circulation is a contributory 
effect to AMD or a secondary effect of 
AMD progression.4 Optical coherence 
tomography angiography (OCTA) can 
be used to better understand how alter-
ations or breakdown in the choriocap-
illaris vessel network of the choroid 
may precipitate and contribute to the 
development of choroidal neovascular, 
or “wet,” AMD.   
In histological studies of retinal 
drusen, vascular density beneath 
drusen has been found to be 45% 
lower than areas adjacent to drusen.5 
This study seeks to use noninvasive 
methods to evaluate the angiographic 
flow of the choriocapillaris in drusen 
subjects to elucidate early vascular 
morphologic changes that may influ-
ence AMD progression. The most 
commonly used vascular diagnostic 
imaging methods in ophthalmology 
are f luorescein angiography (FA) 
and indocyanine green angiography 
(ICGA). Recent advances in optical 
coherence tomography (OCT) imaging 
have led to the development of OCTA 
methods that do not require injection 
of a fluorophore. 
Retinal imaging was performed 
on nine subjects including four AMD 
patients, three age-matched normal 
subjects over 70-years old, and two 
normal subjects less than 40 years 
old. Retinal imaging was acquired 
using a swept-source OCT system 
with a Fourier-Domain Mode-Locked 
laser. Phase-variance OCTA image 
processing was performed after data 
acquisition of multiple repeat B-scans 
collected in a series of images with 
temporal variation. Phase images 
were then corrected for by sub-pixel 
motion of the whole sample by bulk-
phase removal. The variance of the 
phase as a set of vectors can then be 
interpreted as angiographic contrast. 
This enables choriocapillaris retinal 
microvasculature imaging from the 
three-dimensional OCTA data. 
Regions of interest (ROIs) selected 
for a 10 mm thick slab of choriocapil-
laris microvasculature were then 
analyzed for mean signal intensity 
as a measure of angiographic vessel 
density. Qualitative assessment of en 
face choriocapillaris projection images 
from a subject with drusen and AMD 
demonstrate choriocapillaris dropout 
seen with progression of AMD, in 
comparison to the intact microvas-
cular choriocapillaris demonstrated in 
the normal subject (Figure 1). 
Phase-variance angiographic signal 
intensity was significantly decreased 
by over 38% in the drusen subjects 
in comparison to all normal subjects 
(39.98 vs. 64.64, p<0.001). 
Decreased choriocapillaris signal 
intensity seen in the presence of 
drusen demonstrates a pathogenic 
change in vasculature with AMD 
from those seen in the normal aging 
process. Quantitative and qualita-
tive analysis of choriocapillaris using 
OCTA can help further elucidate 
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AMD disease pathogenesis and pro-
gression. Detection of choriocapillaris 
vascular changes without the need 
for injection of a fluorophore with FA 
or ICGA offers a safe, non-invasive 
imaging modality with improved 
ability to render microvascular detail 
in three-dimensional data acquisi-
tions. In the setting of choroidal neo-
vascularization, patients can then uti-
lize anti-vascular endothelial growth 
factor injection therapy earlier in the 
course of wet AMD progression with 
improved preservation of vision. 
REFERENCES
1. Curcio C, Johnson M, Rudolf M, Huang 
J. The oil spill in ageing Bruch mem-
brane. British Journal of Ophthalmology. 
N.d.;95(12):1638-1645. 
 Continued from p. 26 2. Mettu PS, Wielgus AR, Ong SS, Cousins SW. 
Retinal pigment epithelium response to 
oxidant injury in the pathogenesis of early 
age-related macular degeneration. Mol 
Aspects Med. 2012;33(4):376-398.
3. Bhutto I, Lutty G. Understanding age-related 
macular degeneration (AMD): relation-
ships between the photoreceptor/retinal 
pigment epithelium/Bruch's membrane/
choriocapillaris complex. Mol Aspects 
Med. 2012;33(4):295-317.
4. Mullins R, Johnson M, Faidley E, Skeie J, Huang 
J. Choriocapillaris Vascular Dropout 
Related to Density of Drusen in Human 
Eyes with Early Age-Related Macular 
Degeneration.  Investigative Ophthal-
mology & Visual Science [serial online]. 
N.d.;52(3):1606-1612.
5. Mullins RE, Johnson MN, Faidley EA, et 
al. Choriocapillaris Vascular Dropout 
Related to Density of Drusen in Human 
Eyes with Early Age-Related Macular 
Degeneration. Invest Ophthalmol Vis Sci. 
2011;52:1606–1612.
Pushing the Limits: Perinatal Outcomes  
Beyond Prolonged Second Stage
To evaluate whether extremely prolonged second stage of labor in  
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TABLE 1: Selected Maternal and Neonatal Outcomes
We performed a retrospective cohort 
study of term, nulliparous women 
with singleton gestations, cephalic 
presentation, epidural anesthesia, in 
labor, who reached 10 centimeters 
of cervical dilation. Exclusion cri-
teria were intrauterine fetal demise, 
 Continued on p. 28
FIGURE 2: Average chorinocapillaries 
phase-variance angiographic signal 
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planned cesarean delivery, or sus-
pected major fetal anomaly. Women 
were compared by length of second 
stage: 0-179 minutes (normal second 
stage), 180-299 minutes (prolonged 
second stage) and ≥ 300 minutes 
(extremely prolonged second stage). 
Primary outcome was incidence of 
spontaneous vaginal delivery (SVD). 
Maternal and neonatal outcomes were 
compared as secondary outcomes. 
In total, 662 women were evalu-
ated: 115 with extremely prolonged 
second stage (EPSS), 116 with pro-
longed second stage (PSS) and 430 
with normal second stage (NSS). 
Maternal demographics differed by 
age, race, gestational age, diabetes 
and epidural use. Incidence of SVD 
was 93.3% (401/430) in the NSS group, 
86.2% (100/116) in the PSS group, and 
50.4% (58/115) in the EPSS group (RR 
0.45, 95% CI 0.22-0.93) (Table 1). The 
PSS group had a higher incidence of 
3rd degree laceration: 8.6% (10/116) 
vs 3.3% (14/430) in the NSS group 
(OR 2.80; 95% CI 1.17-6.51). The 
EPSS group had a higher incidence of 
postpartum hemorrhage compared to 
the NSS group: 31.3% (36/115) vs 6.0% 
(26/430) (OR 7.04; 95% CI 4.03-12.44), 
3rd degree laceration: 7% (9/115) com-
pared to 3.3% (14/430) in the NSS 
group, (OR 2.52; 95%CI 1.02-5.99) 
neonatal CPAP use: 13.9% (16/115) vs 
4.9% (21/430) in the NSS group (OR 
3.14; 95% CI 1.56-6.26) and composite 
neonatal outcome: 23.5% (27/115) vs 
10.9% (47/430) in the NSS group (OR 
2.50; 95% CI 1.60-4.23).
In nulliparous term women with 
singleton gestations who reached 
10 centimeters cer vical dilation, 
the chance of spontaneous vaginal 
delivery decreased by 55% after three 
hours of second stage and by 97% after 
TABLE 2: Maternal, Obstetric, and Neonatal Characteristics by Length of Second Stage
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five hours of second stage. However, 
most women delivered vaginally, with 
70.4% of women delivering by SVD 
after five hours. The PSS group had 
similar maternal and neonatal out-
comes as the NSS group; whereas the 
EPSS group had significantly worse 
maternal and composite neonatal 
outcomes. Risks and benefits of PSS 
vs. EPSS should be weighed during 
clinical decision making on how long 
to continue labor during the second 
stage.
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Up to 50% of antibiotic use in pedi-
atric intensive care units is for empiric 
treatment of ventilator-associated 
pneumonia (VAP).1 Positive tracheal 
aspirate culture results could repre-
sent colonization or infection, and 
cultures may be positive in clinically 
asymptomatic patients.2 A better 
understanding of the clinical factors 
that lead to the ordering of tracheal 
aspirate cultures and antibiotic pre-
scription in the setting of positive 
tracheal aspirate cultures could help 
us optimize clinical practice.   
We conducted a retrospective 
cohort study of intubated neonates 
admitted to Children’s National 
Health System (Children’s National) 
neonatal intensive care unit (NICU) 
who had tracheal aspirate cultures 
sent between May 2016 and December 
2016. Through chart review, we 
identified clinical factors in the 48 
hours preceding tracheal aspirate 
culture order. These included vital 
sign changes, change in respiratory 
secretions, increase in ventilator set-
ting or oxygen requirement, white 
blood cell count, C-reactive pro-
tein (CRP), and chest X-ray results. 
Outcome measures collected include 
hospital length of stay, NICU length 
Tracheal Aspirate Cultures in Intubated Neonates:  
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FIGURE: Clinical factors noted around time of respiratory culture
Overall  
(n = 51)
No Growth / 





Fever 0/51 (0%) 0/32 (0%) 0/19 (0%)
Hypothermia 10/51 (20%) 6/32 (19%) 1/19 (5%)
Leukocytosis 18/51 (35%) 11/32 (34%) 7/19 (36%)
Leukopenia 3/51 (6%) 1/32 (3%) 2/19 (11%)
Change in secretions 7/51 (14%) 1/32 (3%) 6/19 (32%)
Increase Vent Settings 11/51 (22%) 6/32 (19%) 5/19 (36%)
Increase O2 Requirements 11/51 (220%) 4/32 (13%) 7/19 (37%)
Elevated CRP 18/51 (35%) 11/32 (34%) 7/19 (37%)
Tachycardia 10/51 (20%) 0/32 (0%) 6/19 (31%)
Hemodynamic Instability 31/51 (61%) 22/32 (69%) 9/19 (47%)
of stay, ventilator days, discharge 
on respiratory support, recurrence 
of respiratory infection, broncho-
pulmonary dysplasia, colonization 
with multidrug-resistant organism 
(MDRO), and mortality.
We identified 51 intubated neo-
nates who met inclusion criteria. 
Preterm infants accounted for 84%, 
with a median preterm gestation of 
28 weeks. In the 48 hours preceding 
the culture, patients demonstrated 
hemodynamic instability (61%), leu-
kocytosis (35%), increase in ventilator 
settings (22%), increase in oxygen 
requirement (22%), change in secre-
tions (14%), and elevated CRP (35%).
A pathogen was identif ied in 
37% of isolates. S. aureus (7) was the 
most frequently isolated pathogen, 
followed by K. pneumoniae (5) and 
Enterobacter spp. (4). Antibiotics 
were prescribed for 88% of patients. 
The most frequently prescribed anti-
biotic was vancomycin (67%) followed 
by gentamicin (63%). The median 
number of antibiotic days of therapy 
around the time of culture (+/- 1 week) 
was 14 (IQR: 6, 16).
There is considerable variability 
in the clinical factors noted around 
the time of respiratory culture. Fewer 
than half of respirator y cultures 
identified a pathogen. Antibiotic 
courses were prescribed for most 
(88%) patients.  
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Cer vical spine (C-spine) injuries 
occur in 1.5% of injured children sus-
taining blunt injuries who are seen 
at a trauma center, with a mortality 
rate approaching 20%.1, 2 To prevent 
worsening of a C-spine injur y in 
at-risk patients, the neck should be 
immobilized in a “neutral position” 
to minimize movement until it can 
be examined. We previously observed 
that failure to maintain C-spine sta-
bilization is a frequent error during 
pediatric trauma resuscitations.3 
The objectives were to identify the 
different types of lapses in C-spine 
stabilization during trauma resuscita-
tions and to determine tasks associ-
ated with the lapses. Our secondary 
objective was to evaluate patient and 
resuscitation features associated with 
lapses in C-spine stabilization.  
Fifty-six videos of trauma resus-
citations performed at Children’s 
Nationa l Hea lth Sy stem  were 
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reviewed to identify lapses in C-spine 
stabi l ization. Patient feat u res, 
including Glasgow-Coma Scale (GCS) 
motor score, and resuscitation fea-
tures, including time of resuscitation 
(weekday vs. weekend), were obtained 
from the trauma database and medical 
chart review. Tasks associated with 
lapses were identified through video 
review. The presence, duration, and 
number of lapses were analyzed using 
logistic and linear regression models 
for associations with patient and 
resuscitation features. 
Two types of lapses were observed: 
incorrect in-line stabilization C-spine 
(n=52, 75.4%) and complete lapse in 
stabilization (n=17, 24.6%). The most 
common task performed during a 
lapse was C-spine collar manipula-
tion (n=43, 50.6%). C-spine collar 
manipulation was associated with a 
higher likelihood of a lapse (OR 6.82; 
95% confidence interval (CI) 1.74, 
26.64; p<0.01). The lapse duration 
decreased by 138.31 seconds for a GCS 
motor score of 6 compared to a lower 
GCS motor score (95% CI -217.30, 
-59.32; p<0.001). The number of lapses 
increased by 0.91 for a resuscitation 
performed during the weekend (95% 
CI 0.22, 1.59; p<0.01), by 0.04 for each 
additional task related to oxygen 
delivery performed (95% CI 0.01, 
0.08; p<0.01), and by 0.62 for each 
instance of C-spine collar manipula-
tion (95% CI 0.37, 0.87; p<0.001).
Lapses in C-spine immobilization 
are frequent errors during pediatric 
trauma resuscitations. Most lapses 
are due to improper C-spine stabili-
zation rather than a complete lack of 
stabilization. Tasks performed near 
the head and neck, including oxygen 
delivery and collar manipulation, 
have a high association with C-spine 
immobilization errors. These results 
suggest education focused on high-
risk patient factors, resuscitation fac-
tors, and specific resuscitation tasks 
may reduce the likelihood of lapses 
in C-spine stabilization that occur 
during pediatric trauma resuscitation.
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Resilience, the ability to overcome 
adversity and effectively recover from 
stressful experiences, is a complex 
theory with many contributing fac-
tors. Previous studies have shown that 
condition-specific summer camps for 
children with chronic health condi-
tions increase resiliency and adaptive 
coping skills, change attitudes toward 
the illness, and improve quality of 
life.1,2,3 Further research indicates that 
some modifiable resilience factors to 
improve children’s health outcomes 
include fostering positive appraisal 
styles, bolstering executive function, 
and supporting maternal mental 
health.4 The aim of this study was 
to determine how neuropsychiatric 
comorbid diagnoses such as atten-
tion deficit hyperactivity disorder 
(ADHD), learning disability, and 
anxiety disorder influence the resil-
ience of children with chronic health 
conditions.
Children with chronic health 
conditions including autism, epilepsy, 
cerebral palsy, Tourette’s syndrome, 
sickle cell anemia, neurofibroma-
tosis, congenital heart disease, and 
Type 1 diabetes attended Brainy 
Camps of Children’s National Health 
System and participated in this study 
between 2010–16. Sixty-seven par-
ticipants ages 7-17 completed the 
Connor-Davidson Resilience Scale 
(CD-RISC) questionnaire pre- and 
post-camp. Parents of participants 
reported presence of comorbidities 
including ADHD, learning disability, 
and anxiety disorder. Averages for 
pre- and post-camp 
CD-RISC scores were 
taken for participants 
with ADHD, learning 
disability, or anxiety 
disorder, a nd were 
compared to scores 
for control partici-
pants without each 
comorbidity. 
Averages for a l l 
groups indicated an 
increase in resilience scores. The 
increase was 10.27 points on the 
CD-RISC for the 35 participants 
without ADHD, and 7.95 points for 
the 32 participants with ADHD. 
The increase was 7.61 points for the 
30 participants without learning dis-
ability, and 5.98 points for the 37 who 
had a learning disability. The increase 
was 8.36 points for the 47 participants 
without an anxiety disorder, and 6.38 
points for the 20 with an anxiety 
disorder.
These findings demonstrated a 
positive shift in resilience for all par-
ticipants with chronic health condi-
tions who attended Brainy Camps. 
However, the results indicated larger 
improvements in resilience for partici-
pants without comorbid diagnoses of 
ADHD, learning disability, or anxiety 
disorder. Therefore, modifications 
to the camp environment should be 
considered to further improve the 
camp’s benefit for children with these 
neuropsychiatric comorbidities by 
better accommodating their unique 
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ADHD (-) 35 68.09 78.36 +10.27
ADHD (+) 32 62.53 70.48 +7.95
Learning Disability (-) 30 71.63 79.24 +7.61
Learning Disability (+) 37 60.41 66.39 +5.98
Anxiety Disorder (-) 47 64.55 72.91 +8.36
Anxiety Disorder (+) 20 67.5 73.88 +6.38
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needs. Some limitations of this study 
included small sample size as well as 
possible false reporting of comorbid 
diagnoses from parents. Further 
research is needed to understand how 
other factors, in addition to comorbid-
ities, influence resilience of children 
with chronic health conditions, and 
how interventions such as residential 
summer camps can also impact self-
management and health outcomes.
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Age-related macular degeneration 
(AMD) is a leading cause of vision loss 
in patients older than 65.1 Neovascular 
AMD (nAMD) accounts for 10-15% of 
cases of AMD, and is responsible for 
more than 80% of severe vision loss 
and blindness attributable to AMD.2 
With the advent of intravitreal anti-
VEGF agents, large randomized 
control trials (RCT) showed improve-
ment in visual acuity (VA) at the one 
and two-year analysis. However, 
recent studies examining the long-
term effectiveness of landmark trials 
have reported variable results. 
For example, the Comparison of 
Age-related Macular Degeneration 
Treatments Trial, comparing ranibi-
zumab or bevacizumab injected 
mont h l y or  a s  needed ( PR N ), 
demonstrated that treatments were 
effective through month 24; however, 
the five-year extended outcomes of 
this study, using a PRN method, 
demonstrated that VA gains were not 
maintained.3 Similarly, the seven-year 
outcomes of the SEVEN-UP study 
found an overall decline in vision 
using the PRN method.4 
The purpose of this retrospective 
case study was to examine the clinical 
results and treatment patterns for 
patients with nAMD who were man-
aged with a Treat-Extend-Stop (TES) 
protocol and received ≥50 injections of 
anti-VEGF agents.5
The clinical database of a retina-
only practice was searched for patients 
who had a diagnosis of nAMD and 
were treated with anti-VEGF agents. 
A total of 996 patient records were 
examined between September 2005 
and Januar y 2017. Patients were 
included if they had received 50 or 
more intravitreal anti-VEGF injec-
tions. Participants underwent com-
prehensive ophthalmic examination, 
and were treated with anti-VEGF 
agents bevacizumab, ranibizumab 
or af libercept as indicated. A TES 
treatment protocol was used, and at 
each visit patients also underwent 
clinical examination and relevant 
imaging studies, including BCVA 
vision (converted to ETDRS letters), 
optical coherence tomography and 
fluorescein angiography. 
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Consistent Long-Term Therapy of Neovascular AMD 
Managed by 50 or More Anti-VEGF Injections Using a 
Treat-Extend-Stop Protocol
FIGURE 1: Visual outcome of 
























Seventy-one eyes of 67 patients 
met the inclusion criteria. The par-
ticipants were comprised of 41.8% 
males and 58.2% females, with an 
average age of 82.9±6.2 years. Average 
time to the 50th injection was 77.4 
months. Patients received an average 
of 63.7 injections over an average 
follow-up period of eight years. Prior 
to treatment, the mean VA was 
55.6±17.2 ETDRS letters (Figure 1). 
The mean initial vision was 20/80. 
After 50 injections, average VA was 
65.3±13.1 ETDRS letters (20/50) and 
the average change from baseline was 
9.7±19.6 ETDRS letters (p<0.001). 
Visua l improvement was ma in-
tained through final follow-up, with 
an average ETDRS letter score of 
64.3±14.6 ETDRS letters (20/50-), and 
an average change from baseline VA 
of 8.7±20.2 ETDRS letters (p<0.001). 
This was not significantly different 
compared to vision at the 50th injec-
tion (p = 0.189). Visual gains and losses 
were not significantly correlated with 
the type of anti-VEGF agent used 
(p=0.721).
To our knowledge, our current 
study using a TES method is the lon-
gest to date, with an average follow-up 
time of eight years. The patients in 
this study, who received consistent 
long-term anti-VEGF treatment 
using a TES regimen, had an average 
visual gain of +8.7 ETDRS letters, 
with only 9.9% of eyes losing more 
than 3 lines of VA. Moreover, 35.2% 
of subjects had a 3-line gain over the 
eight years (Figure 2) and an average 
vision of 20/50- overall — a figure that 
is reported by many RCTs within two 
years, but is later lost during exten-
sion studies. This study demonstrates 
that consistent long-term anti-VEGF 
treatment for nAMD is effective, safe, 
and can improve or maintain visual 
outcomes.
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FIGURE 2: Visual gains and losses using consistent anti-VEGF therapy
■  50th injection
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Osteoporosis and resulting fragility 
fractures are a leading cause of dis-
ability, morbidity, and mortality in 
seniors. Increased fracture suscepti-
bility is correlated with suboptimal 
bone quality measures, which are 
thought to be highly influenced by 
genetic factors. Roshandel et al1 deter-
mined that specific receptor activator 
of nuclear factor-kappaB (RANK), 
RANK ligand (RANKL), and osteo-
protegerin (OPG) single nucleotide 
polymorphisms (SNPs), previously 
identified by genome-wide associa-
tion studies (GWAS), are associated 
with bone mineral density (BMD) 
and bone geometry parameters in 
older men. The RANK, RANKL, 
and OPG systems play a vital role in 
the regulation of osteoclasts and bone 
resorption.2 Further investigation 
into genetic variation within these 
genes is essential in order to identify 
those at risk for future fragility frac-
tures. Our study sought to expand 
the results of Roshandel et al,1 which 
focused on the elderly, to determine 
whether R A N K L/ R A N K /OPG 
SNPs rs3018362, rs17665435, rs6567276, 
and rs10505348 influence bone quality 
measures in younger populations. 
The Assessing Inherited Markers 
of Metabolic Syndrome in the Young 
(AIMMY) study comprised healthy, 
young adults (18-35 yrs) from the 
University of Calgary (UC) sub-cohort 
(n = 209). The Bone Health study com-
prised healthy African-American chil-
dren (5-9 yrs, n = 97). The Functional 
Single Nucleotide Polymorphism 
Associated with Human Muscle Size 
and Strength (FAMuSS) study com-
prised healthy, young adults (18-40 yrs, 
n = 891). The bone quality phenotypes 
analyzed included total body BMD 
in AIMMY and total BMD adjusted 
for height in the Bone Health study 
measured by dual energy X-ray absorp-
tiometry (DEXA). For FAMuSS, bone 
quality was analyzed from magnetic 
resonance images (MRIs) of the 
humerus and included polar moment 
of inertia, relative cortical volume, and 
robustness as described by Schlecht 
et a l .3 Th ree SN Ps for R A N K 
(rs3018362, rs17665435, rs6567276) 
and one SNP for OPG (rs10505348) 
were genotyped in the AIMMY sub-
cohort using ThermoFisher’s Applied 
Biosystems Taqman SNP genotyping 
assays. Amplified DNA samples were 
analyzed and alleles were determined 
through allelic discrimination assays 
using Applied Biosystems’s 7900HT 
Real-Time PCR machine. SNPs 
were genoty ped in the FA MuSS 
cohort using Illumina Multi-Ethnic 
Genotyping Array (MEGA). Hardy-
Weinberg equilibrium was tested for 
the allelic frequency of each SNP. All 
outcomes were adjusted for age, and 
analysis of covariance (ANCOVA) was 
used to test for associations. 
Our results did not support those 
of Roshandel et al1 and suggested 
that the SNPs rs10505348, rs3018362, 
rs17665435, and rs6567276 were not 
associated with BMD or any other 
bone quality measures in young adults. 
We suspect that the lack of association 
in our study indicates these SNPs may 
not play a role in the development of 
peak bone mass despite being impor-
tant in determining bone quality in 
seniors. The only association that 
approached significance was rs3018362 
and height-adjusted BMD in males 
in the Bone Health cohort (p = 0.07). 
Our study faced some limitations that 
could have accounted for the lack of 
associations. The RANKL/RANK/
OPG signaling pathway represents 
just a single mechanism in the mul-
tifactorial regulation of bone quality. 
To further characterize the effect of 
RANKL/RANK/OPG variations 
on bone quality phenotypes, future 
studies should evaluate the relation-
ship between these variants and bone 
phenotypes in cohorts of different 
ages and ethnicities. In addition, 
expanding the bone quality pheno-
types analyzed to include peripheral 
quantitative computed tomography 
measures would provide more insight 
into the extent of influence that these 
variants have. 
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Sickle cell disease (SCD) is an inherited 
disorder of red blood cells. Patients 
with SCD suffer end-organ damage 
due to vascular occlusion of small 
vessels during a sickle cell crisis. 
Homozygous SCD patients tend to 
have much higher incidence of sensori-
neural hearing loss (SNHL) compared 
to the general population. The inci-
dence of SNHL in patients with SCD 
reaches 29% in developing nations and 
around 12% in the United States.1  
Despite a high prevalence of 
SNHL in patients with SCD, only 
five cochlear implantation surgeries 
have been reported in this popula-
tion,2-5 four of which were caused by 
the SCD.2-4 All but one patient had 
normal cochleae. The exception was 
a case of partial cochlear ossification, 
which required the insertion of the 
electrode into the scala vestibuli.3
We report a clinical case of a 
patient with SCD who developed 
bilateral profound SNHL sequen-
tially within one year with signs of 
early cochlear duct obliteration found 
during cochlear implantation.
A 19 -year-old fema le patient 
with SCD who had suffered multiple 
episodes of crisis developed severe 
to profound SNHL in her left ear 
precipitated by an acute ear infection. 
Three months later she developed 
severe to profound SNHL in her right 
ear preceded by an acute sickle cell 
crisis following a urinary tract infec-
tion. The patient also complained 
of disequilibrium and bilateral non-
pulsatile tinnitus.
Magnetic resonance imaging 
(MRI) of the brain showed signs of 
subacute bilateral labyrinthitis as 
evident by the absence of normal fluid 
 Continued on p. 36
FIGURE 1: (A) Axial volumetric T2-weighted image (FIESTA) at the level of the internal 
auditory canal (IAC) shows normal fluid signal in the visualized portion of the right lateral 
(solid arrow) and posterior (dashed arrow) semicircular canals. In the corresponding portion 
of the left temporal bone (solid circle), the fluid signal in these structures is absent. (B) 
Axial fluid attenuation inversion recovery (FLAIR) shows abnormal bright signal in the 
right labyrinthine structures (solid circle), consistent with increased protein content. Axial 
(C) and coronal (D) T1-weighted images through the right labyrinthine structures after 
the administration of contrast show patchy enhancement of the cochlea (blue arrow) and 
vestibule (dashed arrow). Axial (E) and coronal (F) T1-weighted images through the left 
labyrinthine structures after the administration of contrast shows patchy enhancement of 
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signal on T2-weighted images, elevated 
protein content seen as abnormally 
bright signal in fluid-attenuated inver-
sion recovery (FLAIR) images, as well 
as patchy enhancement of these struc-
tures after administration of contrast 
(Figure 1).
The patient received bilateral 
cochlear implantation with Med-El 
Synchrony Flex 28 electrodes. Prior 
to surgery, the patient underwent 
exchange transfusion to prevent 
vaso-occlusive crisis. We found pneu-
matized normal mastoids bilaterally 
with a small amount of inflammatory 
tissue in the facial recess and middle 
ear. The hook region of the cochlea 
was partially obliterated bilaterally 
and gentle serial dilations with inser-
tion guides were required for complete 
electrode insertion. Intraoperative 
telemetry measurements revealed 
low impedance and adequate audi-
tory nerve response thresholds. A 
sound field audiogram eight weeks 
after initial activation demonstrated 
thresholds ranging from 25 dB to 50 
dB hearing level (HL) compared to 
profound hearing loss preoperatively 
(Figure 2).  
The cochlea is supplied by the ter-
minal cochlear branch of the labyrin-
thine artery, a branch of the anterior 
inferior cerebellar artery.3 Having a 
solitary terminal blood supply makes 
the cochlea quite vulnerable to vas-
cular occlusion caused by sickled red 
blood cells during sickle cell crises. 
Also, transient occlusion of the ante-
rior inferior cerebellar artery may lead 
to altered hemodynamics and reper-
fusion injury, which may cause laby-
rinthine hemorrhage. This phenom-
enon is theorized to incite reparative 
response that cascades from fibrosis 
to sclerosis to ossification of the inner 
ear structures.
 Continued from p. 35
Considering the high incidence 
of SNHL in SCD patients, screening 
audiograms and education of parents 
and primary physicians in the urgency 
of SNHL is important. As we currently 
do not possess adequate treatment for 
cochlear infarction or hemorrhage 
in these patients, cochlear implanta-
tion remains the treatment of choice. 
Expedited cochlear implantation 
may provide more satisfactory results 
as cochlear fibrosis tends to happen 
quickly in these patients.
 Continued on p. 36
FIGURE 2: Cochlear implant thresholds to warbled tones in the sound field eight 
weeks after initial cochlear implant activation (star for the left and diamond for the right). 
No response from either ear at equipment limits to pure tone air conduction stimuli 
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Latent human immunodeficiency 
virus (HIV) infection within long-
lived cells establishes a persistent 
reservoir that is a major barrier to cure. 
Pharmacologic reversal of HIV latency 
has been proposed as a mechanism to 
promote cytotoxic active infection and 
the elimination of persistent viral res-
ervoirs. Using in vitro models of HIV 
latency, combinations of transcription 
factor activating agents with histone 
deacetylase inhibitors (HDIs) have 
been shown to synergistically reverse 
HIV latency. However, these results 
have not translated into positive effects 
in in vivo or in ex vivo experiments 
using HIV-infected patient-derived 
CD4+ T-cells.1-4 Importantly, HDIs 
that affect a broad range of isoforms 
of histone deacetylases (pan-HDIs) 
have been the focus of most of these 
 Continued on p. 38
FIGURE 1: Entinostat plus bryostatin-1 induces maximum viral outgrowth in latently 
infected CD4+ T-cells from HIV-infected individuals. HIV viral outgrowth from patient-
derived CD4+ T lymphosytes treated with indicated drugs (mean ± standard deviation 
of experimental duplicates). Limit of quantification is indicated by the dotted horizontal 
line. P values were calculated by unpaired student’s t-tests. ** p<0.01.
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FIGURE 2: Entinostat plus bryostatin-1 clears infected cells from culture. (a) 
Schematic of the in vitro clearance assay. PLAP is expressed from the HIV genome 
in place of Env and serves as a marker of active infection. (b) Representative flow 
cytometric analysis of infected cells one day and four days after treatment. Numbers 
indicate percentage of cells within the gate. Bracketed numbers indicate the mean 
fluorescence intensity of PLAP for cells within the gate. (c) Summary graph showing 
inverse correlation between frequency of residual infected cells on day four as in part 
(a) and induced viral outgrowth per PLAPpos cell after first 24 hours of treatment. 
Hematopoietic stem and progenitor cell (HSPC), latency-reversing agent (LRA).
studies, despite the knowledge that 
HIV latency is only affected by class I 
histone deacetylases.5 Therefore, we 
hypothesized that the combination 
of the class I-selective HDI entinostat 
plus the NF-κB agonist bryostatin-1 
would maximally reverse HIV latency 
from CD4+ T-cells from HIV-infected 
donors and reduce the latent viral 
reservoir.
When we treated CD4+ T-cells 
f rom HI V-i nfected people, we 
detected virus outgrowth at 24 and 
48 hours with bryostatin-1 alone in 
three of four donors. Remarkably, we 
detected significantly more virus out-
growth with the combination of bryo-
statin-1 plus entinostat (Figure 1; 5- to 
11-fold). Concomitant with increased 
virion release, we also detected more 
cell-associated HIV mRNA when 
cells were treated with bryostatin-1 
plus entinostat compared to bryo-
statin-1 alone in all four donors (data 
not shown). Collectively, these data 
are the first example of any HDI 
enhancing virus outgrowth from 
patient samples.
To test the effect of treatment 
conditions on the elimination of latent 
viral reservoirs, we developed a novel 
primary human hematopoietic stem 
and progenitor cell HIV latency model 
system (Figure 2a). Using this system, 
we quantified the potency of induced 
HIV latency-reversal (supernatant 
HIV mRNA) and the frequency of 
infected cells that emerged one day 
after treatment and remained after 
three days in culture without any 
stimulus. One day post-treatment, 
the frequency of induced PLAPpos 
cells was similar among all conditions 
tested except for our negative DMSO 
control (Figure 2b). Consistent with 
previous work,2 HIV protein produc-
tion was most potently induced by 
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(Figure 2b). Interestingly, it was only 
this combination of entinostat plus 
bryostatin-1 that then reduced the 
frequency of residual infected cells 
in culture four days post-treatment 
(Figure 1b). Finally, we demonstrated 
a strong inverse correlation between 
the potency of induced viral outgrowth 
from latently infected cells (superna-
tant HIV mRNA) and the frequency 
of residual actively infected cells in 
culture four days after treatment 
(Figure 1c).
In summary, our results dem-
onstrate that the combination of 
the class I-selective HDI entinostat 
plus bryostatin-1 maximally reverses 
HIV latency and promotes reservoir 
elimination. We have also shown that 
pan-HDIs limit potent HIV latency-
reversal due to inhibition of important 
proviral factors (Hsp90 and NF-κB) 
affected by the activity of non-class I 
histone deacetylases (data not shown). 
Therefore, this supports the rationale 
of the development of a more tar-
geted latency-reversal regimen that 
avoids nonspecific/off-target effects, 
advances the field toward the goal 
of eliminating the viral reservoir in 
HIV-infected people, and contributes 
to a cure.
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Recent studies have begun to search 
for correlations between genetic varia-
tions and muscle strength. One such 
study, by Stebbings et al.1, examined 
two single nucleotide polymorphisms 
(SNPs) — rs7843014 and rs7460 — on 
the PTK2 gene. The study found that 
genetic variation in the PTK2 gene 
impacts muscle-specific force, which 
is measured as force generated per 
unit of cross-sectional area of muscle. 
PTK2 is responsible for costamere 
formation and turnover in striated 
muscles. Costameres function to 
attach the Z-line to the sarcolemma 
and in turn regulate the amount of 
muscle-specific force a muscle can 
exert. Muscle-specific force ultimately 
represents the intrinsic strength of 
a muscle and is a key determinant 
of functional capacity and mobility. 
This study sought to expand on prior 
research by looking for associations 
between genetic variants of PTK2 and 
measures of grip strength, as well as 
general anthropomorphic measures, 
in a cohort of healthy young adults. 
Our study used the Assessing 
Inherited Markers of Metabolic 
Syndrome in the Young (AIMMY) 
University of Calgary subset con-
sisting of 190 healthy, primarily 
Caucasian individuals between the 
ages of 18 and  35. We assessed their 
phenotypes for height, weight, VO2 
max, max grip strength, and body 
mass index (BMI). DNA samples 
from these patients were genotyped 
using ThermoFisher Taqman SNP 
genotype assays. After completion, 
the samples underwent the Applied 
Biosystems 7900HT real-time poly-
merase chain reaction (PCR) process. 
Analysis of covariance (ANCOVA) 
models were then used to perform sta-
tistical analysis to look for genotype-
phenotype associations and ensure 
Hardy-Weinberg equilibrium. 
Unlike the findings by Stebbings 
et al.,1 we did not find an association 
between the PTK2 genotypes and 
grip strength. This may indicate that 
grip strength and muscle-specific 
force do not measure similar param-
eters of muscle strength. Stebbings 
et al.1 used a leg press to measure the 
muscle-specific force of the quadri-
ceps, while a hand strength dynamom-
eter was used to assess grip strength in 
the AIMMY cohort. Although both 
are pennate muscles, the hand muscles 
pale in comparison to the quadriceps, 
which are the largest muscle groups 
in the body. It has been found that 
larger muscles generate proportion-
ally greater amounts of force, so the 
difference could be related to a lower 
statistical power in the grip strength 
test. Genetic variation in PTK2 has 
also been previously associated with 
VO2 max, but no association was 
found in the current study.
Interestingly, positive associations 
were found between genetic variants 
rs7843014 and rs7460 in PTK2 and 
BMI, although not found in previous 
studies.1,2 Individuals with high levels 
of functioning PTK2 have been 
found to have increased strength due 
to increased costamere density. A 
higher costamere density equates to 
more muscle myofibrils, which results 
in larger and presumably heavier 
muscles. This finding was sexually 
dimorphic and only observed in males. 
This could be attributed to differen-
tial acquisition and maintenance of 
muscle mass based on sex. There was 
also an association between genetic 
variant rs7843014 and height in males.
We identified a potentially novel 
association between genetic variants 
in PTK2 and anthropomorphic phe-
notypes, specifically BMI and height. 
 Continued on p. 40
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in educating their peers, but with little 
guidance or preparation.3
However, we were unable to confirm 
the effects of genetic variants on 
measures of intrinsic muscle strength, 
namely max grip strength or VO2 
max in terms of functional capacity. 
 Continued from p. 39 Further research is needed to confirm 
this newly identified role for PTK2.
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better prepared to treat vulnerable 
patients than students in a conven-
tional curriculum.2 Furthermore, 
physicians are also expected to engage 
Providers are inevitably faced with 
treating economically disadvantaged 
and culturally diverse populations. 
To meet the needs of socially complex 
patients, further training is warranted. 
One way of addressing this need is 
through service learning, defined as 
active community engagement with 
ongoing student reflection.1 Students 
that engage in service learning are 
41MEDICAL EDUCATION
FIGURE 1: Weasis interface accessed using hospital computer screenshot. Using 
browser to serve as a DICOM viewer without special software required, and all functions 
(window width and level, zoom, measurement, etc.).
Current radiology training in medical 
schools is still predominantly limited 
to passively observing the radiologist 
at the workstation and through 
lectures, textbooks, a nd on line 
sources. Evaluation is also mainly 
limited on still image interpretation 
or knowledge-based multiple-choice 
questions.1 In order to create a tailored 
and active learning experience, and 
to evaluate students’ ability in image 
interpretation, we utilized an open-
source web-based Picture Archiving 
and Communication System (PACS) 
na med “ Wea sis” w ith ou r ow n 
reporting system.2,3 
Attending radiologists can send 
desired anonymized studies from 
hospital PACS during read-out to a 
shared secure server on the hospital 
network. Cases can be immediately 
accessed by trainees on any computer 
connected to the shared network. 
St udents ,  s i mu lt a ne ou sl y,  ca n 
We aim to address these needs by 
expanding an existing Community 
Hea lth Care elective at George 
Washington University’s (GW) free 
student-run Healing Clinic. We 
are developing a curriculum that 
is founded in service learning with 
a particular emphasis on cultural 
competency, cost-conscious care, and 
developing students into educators.  
In addition to group reflection, 
surveys will be distributed to stu-
dents in the elective assessing several 
aspects, including, but not limited 
 Continued from p. 40 to: satisfaction with the elective, 
confidence in the preceptor role, con-
fidence in balancing cost with quality 
care, understanding of SDOH, and 
impact on future practice. 
As young providers entering the 
field, we will be faced with serving 
a complex and diverse patient popu-
lation. Community engagement is 
one important way to better prepare 
providers. Through the proposed cur-
riculum, we hope to further prepare 
our peers and ourselves to promote 
health equity. Data from the surveys 
will be evaluated throughout the year. 
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 Continued on p. 42
FIGURE 2: Flow chart of the PACS teaching system. 
simulate being a radiologist and 
independently formulate an opinion 
and write up a brief report, without 
the need for occupying an expensive 
PACS workstation. Trainees can 
access a list of cases to create a very 
short report for each case, which can 
later be reviewed by a resident or an 
attending radiologist. This can be 
used for examination purposes, both 
for radiology rotation evaluation of 
medical students and as part of the 
pre-call Objective Structured Clinical 
Examinations of first-year residents.
We establ ished a new PACS 
teaching system by utilizing the open-
source PACS system “dcm4chee” and 
integrating Weasis as an imaging 
viewing browser, MySQL as a database, 
and JBOSS as an application server. 
The developmental environment is 
MyEclipse, and the developmental 
language is JAVA. We used WADO 
( Web Access to Digital Imaging 
and Communications in Medicine 
(DICOM) Object) to achieve web-
client DICOM image access.2 Java 
applets are used via a browser to serve 
as a DICOM viewer without special 
software required, and all functions 
(window width and level, zoom, 
measurement, etc.) are provided as 
 Continued from p. 41
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controls within the server application.3 
However, Weasis does not come with 
a reporting system, so we built one 
using the same methodolog y for 
student reporting and preceptor 
commenting and grading. 
By implementing Weasis and 
the add-on reporting system, a real-
time, easy-access, sophisticated 
Image Database can be established. 
The content of examination will 
be more versatile and similar to 
clinical scenarios. Therefore, this 
implementation provides a new 
opportunity for both training and 
evaluation purposes for radiology 
programs.
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Chronic hepatitis C virus (HCV) 
infection is a preva lent disease 
among veterans with a rate 2-3-fold 
higher than that of the general popu-
lation within the United States.1 
Co-infection with HCV has been esti-
mated in nearly 40% of HIV-infected 
veterans.2 Recent advancements in 
HCV treatment have resulted in a 
shift from pegylated interferon-based 
regimens to the use of directly acting 
agents (DAA).3 The goal of HCV 
treatment is to achieve sustained 
virologic response (SVR), which has 
been associated with lower rates of 
end-stage liver disease, hepatocel-
lular carcinoma, and death.4 From 
prior studies on HCV infection in 
the general population, pegylated 
interferon-based regimens resulted in 
SVR rates of 41% among HCV mono-
infected patients and 27% among 
HCV/HIV co-infected patients.5 
However, approximately 90% of all 
patients have attained SVR after 
DAA treatment.4
At t he Wa sh i ng ton DC VA 
Me d ic a l  C enter  ( D C -VA MC ), 
pegylated interferon-based regimens 
were used to treat HCV infection 
during 2008-13, and DAAs became 
the preferred treatment in 2014-15. 
We describe HCV-related diagnoses, 
calculated liver scores, and mortality 
for our patients during 2008-15 at the 
DC-VAMC in the Table.
Among al l patients, 20% had 
the diagnosis of cirrhosis without 
mention of alcohol by ICD-9 code 
571.5 with no significant difference 
between the proportions of mono- 
and co-infected patients with cir-
rhosis. Among all patients, 5% had the 
diagnosis of primary malignant neo-
plasm of the liver by ICD-9 code 155.0, 
with a significantly greater propor-
tion of HCV mono-infected patients 
having hepatocellular carcinoma than 
HCV/HIV co-infected patients (5% 
vs. 2%, p=0.0158 by 2-tailed Fisher’s 
exact test). For calculated liver scores, 
a significantly greater proportion of 
HCV/HIV co-infected patients had 
Fibrosis-4 (FIB-4) >3.25 compared to 
HCV mono-infected patients (31% vs. 
25%, p=0.0035 by 2-tailed Chi-square 
with Yate’s correction). However, 
similar proportions of mono and co-
infected patients had AST to Platelet 
Ratio Index (APRI)>1.5 (13% vs. 14%, 
p=0.4307 by 2-tailed Chi-square 
with Yate’s correction), MELD score 
 Continued on p. 44
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TABLE: Summary of Hepatitis C (HCV) parameters and clinical outcomes where 
numbers (% of group total) for all HCV patients between 2008–15 (1Two-tailed Fisher’s 
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2008–15 934 (18%) 850 (18%) 84 (20%) 0.42622
44 Fusion ♦ 2018
>30 (2% vs. 3%, p=0.3674 by 2-tailed 
Fisher’s exact test), and MELD-Na 
score >30 (3% vs. 4%, p=0.3729 by 
2-tailed Fisher’s exact test). There 
were no differences in all-cause mor-
tality between mono- and co-infected 
patients (18% vs. 20%, p=0.426 by 
2-tailed Chi-square with Yate’s cor-
rection) annually and during our 
entire study period.
We found a significantly higher 
proportion of HCV mono-infected 
patients with a diagnosis of hepa-
tocellular carcinoma compared to 
co-infected patients. This outcome 
may ref lect differences in patient 
populations, as our HCV/HIV co-
infected patients were predominantly 
men with high CD4 counts >400 cells/
mm3. In addition, our patients’ HIV 
infections were fairly well controlled, 
with 78% achieving HIV suppression 
on antiretroviral therapy during the 
study period. Although FIB-4 was 
the only significantly different liver 
score, suggesting a greater proportion 
of co-infected patients had advanced 
hepatic fibrosis or cirrhosis, FIB-4 
has been viewed as a better predictor 
for the clinical outcomes of hepatic 
decompensation, hepatocel lular 
carcinoma, and mortality compared 
to Child-Turcotte-Pugh and MELD 
scores.4 Nevertheless, there were no 
differences between our two groups 
for the diagnosis of cirrhosis without 
mention of alcohol and all-cause mor-
tality during the study period. 
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Over the last few decades, scope-of-
practice laws for nurse practitioners 
(NPs) have changed rapidly, allowing 
for increased practice and prescribing 
autonomy in the hopes that these 
providers can help alleviate some of 
the workforce shortages in primary 
care that exist all over the United 
States. Despite this trend toward 
enhanced autonomy, scope-of-prac-
tice laws vary widely by state, this 
includes rates of reimbursement to 
NPs paid for by Medicaid, with some 
states reimbursing NPs at 100% of 
the physician rate and others only 
reimbursing at 75% of the physician 
rate1. At the federal level, Medicare 
implemented legislation in 1998 that 
began reimbursing NPs at a rate of 
85% of a physician’s fee regardless of 
site of practice or geographic loca-
tion, a change from previous versions 
that restricted NP reimbursement 
to rural areas and sites specific to 
long-term or follow-up care2. Since 
then, the number of NPs who have 
been billing on their own has been 
increasing over time. The current 
study examined whether a change in 
scope-of-practice law toward a more 
autonomous practice changed the rate 
at which NPs billed independently for 
their services.
This project used a 5% sample 
of Medicare claims data from 1999 
to 2014 to track the pattern in the 
number of NPs who were billing 
Medicare for their services. In order 
to bill Medicare as an independent 
provider, NPs would need to have 
their own National Provider Identifier 
(NPI). Unique NPI numbers were 
totaled and plotted over time by the 
state to evaluate the change in trends. 
State changes to NP laws were iden-
tified and catalogued through use of 
West Law, a legal research service that 
archives state legislative and regula-
tory changes. After identifying all 
relevant changes to scope-of-practice 
laws for NPs by state, NP billing 
trends were evaluated at times before 
and after these had gone into effect.
Changes in scope-of-practice laws 
for NPs did not change the trends in 
the number or rate of these providers 
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FIGURE: Trends in nurse practitioner independent Medicare billing rates, Wyoming 
and Maryland, 1999–2014
billing for their services. The number 
of NPs billing independently for 
Medicare had been increasing steadily 
over time. In a given state, a change 
toward more autonomy in practice 
did not affect the rate of the increase. 
The same trend was also seen in 
states that had the most dramatic 
changes in their laws. Examples of 
this can be seen in Figure 1. In 2005 in 
Wyoming and 2010 in Maryland, each 
state passed legislation removing the 
requirement for NPs to have a collab-
orative agreement with a physician, 
effectively allowing for independent 
practice. Yet, the figures show the 
trends in NPs billing independently 
was consistent with rates seen before 
these legislative changes.
Understa nd ing the effect of 
changing scope-of-practice laws on 
NP practice patterns will be essen-
tial to informing current and future 
regulation of these providers. While 
this trend has been increasing steadily 
over time, the rate at which NPs billed 
Medicare independently did not 
dramatically change with increased 
practice and prescribing autonomy in 
state legislation, which may be a key 
piece to alleviating some of the strain 
on the primary care workforce. 
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How the European Union Is Embracing Cross-Border 
Telemedicine and What the U.S. State Medical Boards  
Can Learn From It
Despite the many advances in the 
field of telemedicine, U.S. state and 
federal laws have not kept pace with 
these technological advancements 
and may operate as a barrier to growth 
in the field. On the other hand, the 
European Union has developed a 
robust legal framework for the prac-
tice of telemedicine. The aim of this 
research project is to evaluate what 
elements of the EU legal experience 
could be used to support efforts to 
better align telemedicine law with 
the practice of telemedicine in the 
United States.
Based on the 2015 EU Guidelines, 
by 2020, a French physician may be 
able to see a German patient online 
and have instant access to the patient’s 
medical record, automatically trans-
lated into the French language.1 The 
EU has prioritized the creation of 
a legal framework that fully sup-
ports cross-border telemedicine.2 
As early as 2000, the EU broad-
ened medical licensure requirements 
for telemedicine so that physicians 
licensed in one nation could provide 
telemedicine services to patients who 
reside in other EU nations without 
needing to obtain medical licenses 
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from these nations.3 Furthermore, lin-
guistic experts from several nations of 
the EU have been working together to 
develop ways of automatically trans-
lating and instantly delivering patient 
records to physicians, as appropriate.1
The state medical boards of the 
U.S, however, have struggled with 
efforts designed to achieve similar leg-
islative changes. In most states, phy-
sicians are required to be licensed in 
both the state where they practice and 
the state where the patient resides.4 
For example, a Texas physician is 
required to obtain a Georgia medical 
license in advance of providing tele-
medicine care to a patient in Georgia 
to ensure that their services are legal 
and reimbursable by insurance. 4 
While some states now provide a 
telemedicine license or expedite mul-
tistate licensing, these measures are 
insufficient to support the widespread 
practice of interstate telemedicine.4 
With current regulations, obtaining 
medical licenses in all 50 states for 
telemedicine practice is impractical 
and prohibitively expensive for health 
care providers and organizations.  
U.S. medical licensure require-
ments for telemedicine practice 
are comparable to EU regulations 
before 2000. Furthermore, U.S. tele-
medicine reimbursement regulations 
arbitrarily differ across state borders, 
and electronic medical record systems 
from various companies do not com-
municate properly with each other. 
At this time, physicians in the United 
States cannot retrieve patient records 
for unscheduled patient encounters in 
real-time unless the patient was previ-
ously treated using the same medical 
health records system, causing incon-
venience to patients, treatment delays 
and duplicative medical testing.5 
Similar to the European approach, 
we recommend that the state medical 
boards allow physicians licensed in 
one state to provide telemedicine 
services to patients in other states. 
Furthermore, we recommend col-
laboration among the state medical 
boards, industry leaders, and state 
legislatures to come up with uni-
form telemedicine reimbursement 
regulations and to design a uniform 
electronic medical record inter-
operability standard to allow the 
U.S. telemedicine industry to keep 
abreast of the global developments in 
telemedicine. 
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Family-Centered Rounds (FCR) is 
defined as a model that emphasizes 
bedside rounding as intentional 
inclusion of the patient and family in 
partnership with physicians, nurses, 
and staff.1 Though families have 
generally reported positive experi-
ences with FCR2, limited English 
proficiency (LEP) families often face 
additional challenges due to inad-
equate provision of a licensed inter-
preter.3 Children’s National Health 
System (Children’s National) has been 
utilizing the FCR model with success 
for several years, however, the current 
protocol lacks a reliable and consistent 
notification system for all parties. 
Nurse, family, and interpreter involve-
ment in FCR at Children’s National 
could be enhanced by developing 
a specialized FCR mobile applica-
tion to improve communication and 
coordination between the various 
stakeholders involved in a child’s care. 
The goal of the study was to col-
lect and analyze data concerning the 
process of nurse, interpreter, and 
family inclusion in FCR at Children’s 
Understanding Nurse, Family, and Interpreter 
Involvement in Family-Centered Rounds at 
Children’s National Health System 
Saadia Nawal, 
MSII, and 











TABLE 1: Nurse Data
When 
contacted











76.28 30.70 45.58 00:02:21
At start/after 
rounds (n=82)
58.54 1.22 57.32 00:03:31
Not at all 
(n=135)
55.56 28.15 27.41 00:01:25
National. We used REDCap4 to 
design data collection instruments 
that were completed daily via objec-
tive obser vation while accompa-
nying academic hospitalist teams on 
morning FCR. The data collected 
included measures of medical team 
communication with nurses, stake-
holder presence at rounds, and provi-
sion of a licensed interpreter for LEP 
families. 
One aim of our study was to 
examine current attendance rates 
for all parties involved in successful 
completion of FCR: bedside nurses, 
families, and interpreters. Medical 
teams contacted nurses only 59% of 
the time for FCR, which negatively 
affected nurse attendance rates (Table 
1). Additionally, when the nurse was 
contacted it affected nurse pres-
ence and the amount of information 
missed on rounds. When nurses were 
contacted before rounds started, their 
presence increased by 31% compared 
to nurses who were contacted at the 
start/after rounds started (Table 1). 
The average time of rounds missed 
also decreased by 1 minute and 10 
seconds. Additionally, more nurses 
were present the entire time when 
contacted before rounds, as compared 
to being contacted at or after the start 
of rounds or not at all. This dem-
onstrates the importance of giving 
nurses adequate time to get to rounds, 
a task which can be better facilitated 
by a mobile app notification system. 
Nurses are an extremely impor-
tant source of information when it 
comes to patient care: they have the 
most accurate knowledge of a patient’s 
well-being, diet, and excretion, which 
are extremely important in creating 
a patient’s daily care plan during 
rounds. The nurses also implement 
the plan created by the doctors, so 
including them in FCR is imperative 
for better patient care.  
Another aim of our study exam-
ined family presence and involvement 
during FCR, especially comparing 
English proficient (EP) and LEP 
families. LEP families were present 
 Continued on p. 49
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more often than EP families for FCR, 
but were offered FCR less frequently 
(Table 2). Notably, a licensed inter-
preter was offered only 58% of the 
time for LEP families. This demon-
strates that language is a barrier in 
facilitating FCR and protocol changes 
are needed to eliminate this disparity. 
This study demonstrates a need to 
better facilitate FCR among doctors, 
nurses, families, and interpreters at 
Children’s National. The preliminary 
data shows low nurse attendance, 
disparities in FCR being offered to 
LEP vs. EP families, and a lack of 
licensed interpreter use. We hope 
that technology, such as a mobile app 
notification system, can facilitate 
better communication and coordina-
tion between all parties, ultimately 
improving patient care. 
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TABLE 2: Family Data











English Proficient (EP) 79.80 87.19 97.13 N/A
Limited English Proficiency (LEP) 88.06 79.66 95.74 58.73
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